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Abstract

Acute lymphoblastic leukemia (ALL) can cause a multitude of neuropsychological
sequelae, or late effects, in children following intensive medical treatment. Late effect research
has focused primarily on non-motor related sequelae; however, recent studies have begun to
highlight evident impairments in motor functioning during and following medical treatment. The
following study aimed to further characterize multiple domains of motor functioning in children
treated for ALL compared to healthy controls, as well as investigate the relationship between
motor impairments and other areas of functioning, including academic and psychosocial. The
study included a cross-sectional design with a sample of 13 children treated for ALL and 13 ageand sex-matched healthy controls. Performance based measures were used to assess motor,
academic, and cognitive abilities, along with self- and parent-reports of psychosocial and motor
functioning. Results revealed that the ALL survivor group performed significantly worse than
the control group on tasks assessing visual perception, fine motor skills, and gross motor skills.
No significant differences were observed between the groups in motor learning and visual-motor
functioning. A significant relationship was observed between fine motor and visual-motor
functioning in the ALL survivor group, though motor skills were not significantly associated
with academic skills and most domains of psychosocial functioning. The present findings
provide additional evidence for motor impairments in pediatric ALL survivors and partial
evidence for interrelations between motor skills and other domains of functioning. Present
findings shed light on the need for clinical screening and interventions for motor skills in the
survivor population as well as continued research on motor functioning within pediatric ALL
survivors.
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Chapter 1: Introduction

Pediatric cancer diagnoses occur in approximately 17 out of 100,000 children each year,
with over 15,000 new cases each year (Howlander et al., 2016; Ward, DeSantis, Robbins,
Kohler, & Jemal, 2014). Acute lymphoblastic leukemia (ALL) is the most common child
malignancy above all other forms of childhood cancer diagnoses, including brain and central
nervous system tumors, neuroblastoma, Hodgkin disease, and other forms of leukemia
(Howlander et al., 2016; Ward et al., 2014). Among cases of childhood cancer, approximately
26% are diagnosed with ALL each year (Butler & Mulhern, 2005; Howlander et al., 2016). ALL
is a malignant disorder that impacts lymphoid cells in bone marrow can eventually migrate
throughout the entire body and central nervous system (CNS; Butler & Mulhern, 2005).
Children diagnosed with ALL must undergo intensive systemic treatment to eradicate the
cancer from their blood. During the 1970s, survivorship rates were poor, with approximately
58% surviving; however, recent reports suggest event-free five-year survival rates are as high as
90% in developed countries (Atkinson et al., 2015; Bruzzi et al., 2014; Howlander et al., 2016).
The progressively increasing survival rates have been attributed to client-centered treatment of
ALL with optimal antileukemic agents and individualized cell-based treatment approaches (Pui
et al., 2012). Given the increase in survivorship, higher prevalence amongst pediatric cancer
diagnoses, and higher degree of diagnostic homogeneity compared to other forms of childhood
cancer, the ALL survivor population has become an optimal group for researching long-term
outcomes following childhood cancer treatment.
Survivorship research has been highly focused on understanding the long-term morbidity
associated with ALL treatment. Morbidity rates following treatment have increased along with
survivorship rates with approximately two-thirds of survivors experiencing chronic treatment
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related conditions (Phillips et al., 2015; Smith et al., 2013). The most common morbidities
observed in the survivor population include pain, obesity, and neurocognitive dysfunction
(Atkinson et al., 2015; Phillips et al., 2015). In addition, cancer-related cognitive dysfunction
affects approximately one third of childhood cancer survivors in the U.S. (Krull et al., 2013;
Phillips et al., 2015). Assessments of neuropsychological functioning in children with ALL,
proximal and distal to diagnosis, have revealed impairments across multiple domains of
neurocognitive functioning including attention, processing speed, memory, executive
functioning, intelligence, academic achievement, and motor related skills (Brown, Sawyer,
Antoniou, Toogood, & Rice, 1999; Cheung & Krull, 2015; Krull et al., 2011; Krull et al., 2013;
Peterson et al., 2008; Raymond-Speden, Tripp, Lawrence, & Holdaway, 2000; Robinson et al.,
2010). Impairments in these domains have been related to long-term impacts on education,
employment, and overall quality of life in the survivor population (Krull et al., 2013). Moreover,
neurocognitive late effects and the related long-term impact on functioning illustrate the ongoing
cost of curative interventions for pediatric cancer.
While many late effect studies in pediatric oncology have focused on deficits in attention
and academic skills in ALL survivors, more recent literature highlights a consistent pattern of
evidence for significant weaknesses in motor functioning (Green, Knight, McCarthy, & De Luca,
2013). Furthermore, reported deficits in motor functioning, including fine motor, gross motor,
and visual-motor impairments, have been observed both during and following cancer therapy for
pediatric ALL (De Luca et al., 2013; Green et al., 2013; Hartman, van den Box, Stijnen, &
Pieters, 2006; Wilson, Gawade, & Ness, 2015). Available literature is variable with regard to the
onset, severity, and trajectory of motor impairments (Green et al., 2013). In spite of evidence
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supporting various forms of motor impairments in survivor populations, further examination of
the presentation, trajectory, and etiology of these symptoms is warranted.
Possible cascading effects of motor impairments in child survivors of ALL have yet to be
thoroughly assessed. Understanding motor development is essential due to the vital role motor
functioning plays in healthy development in children (Gotte, Kesting, Winter, Rosenbaum, &
Boos, 2015). According to white matter models, which have been used to conceptualize
nonverbal learning disabilities (NLD), impairments in visual-motor functioning may be
secondary to fine motor and visual-spatial impairments, followed by tertiary impairments in
academic and social functioning (Rourke, 2002). Similar to characteristics of NLD, children with
ALL often experience motor, visual-spatial, and social difficulties (Carey et al., 2007;
Hockenberry et al., 2007). As a result, the white matter model was utilized in the following study
to conceptualize the manifestation of subsequent impairments related to motor weaknesses in
pediatric ALL survivors.
The current study aimed to gain insight into the motor functioning of child survivors of
ALL treated with chemotherapy only. The following review highlights the existing empirical
evidence for motor impairments in pediatric ALL, followed by a review of the etiology of motorrelated late effects. Additionally, the utility of employing clinical and experimental measures for
assessing motor impairments is presented. Finally, the research design and methodology of the
present study are described. Following the literature review, a detailed description of the results
of the study as well as a discussion of the relevance of these findings are provided.
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Chapter 2: Motor Functioning in Pediatric ALL
Within pediatric oncology literature, multiple aspects of motor functioning have been
evaluated. Several researchers have focused on day-to-day motor functioning as reported by
parents and children. Alternatively, other studies have highlighted motor impairments in ALL
survivors utilizing objective clinical and experimental measures of motor skills. The following
review includes a summary of the various manifestations of motor impairments reported in
pediatric ALL literature.
2.1 Physical Activity
In general, children treated for ALL reportedly experience significant reductions in
physical activity during and following cessation of treatment (Gotte, Taraks, & Boos, 2014).
During treatment, pediatric cancer survivors, including ALL, treated with chemotherapy and
radiation have self-reported decreased interest in sport activities and physical exercise (Gotte,
Kesting, Winter, Rosenbaum, & Boos, 2014). Additionally, pediatric ALL survivors treated with
chemotherapy and radiation are less involved in sport activities, including club and school sports,
following treatment cessation according to parent- and self-reports (Beulertz, et al., 2015).
Specifically, ALL survivors treated with only chemotherapy have displayed impairment on a
variety of physical activities compared to healthy controls, including playing outdoors, walking,
muscle strength, sit ups, and jumping (Hartman, Hop, Takken, Pieters, van den Heuvel-Eibrink,
2012; Hoffman et al., 2013; Jarvela et al., 2010; Schoenmakers et al., 2006). Considering
insufficient physical activity is a prominent concern among pediatric ALL survivors throughout
and following treatment, further research is needed to assess both the impact of decreased
physical activity on the ALL survivors’ overall physical and emotional wellbeing, as well as the
underlying etiology of decreased physical activity.
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2.2 Gross Motor
Similar to decreases in general physical activity, children treated for ALL have also
demonstrated impairment in gross motor skills. Reported gross motor deficits have included
balancing, ball skills, coordination, reaction time, agility, and muscular strength (Green et al.,
2013). Gross motor impairments have been observed at various points throughout ALL
treatment, with reports of approximately 50 to 90 percent of children experiencing gross motor
deficits during cancer treatment, including those treated with only chemotherapy (ReindersMesselink et al., 1999) and those treated with chemotherapy and radiation (Gotte et al., 2015).
On a common measure of gross motor skills, the Movement Assessment Battery for Children
(MABC), children with ALL treated with only chemotherapy have displayed impairment in
gross motor skills in ball skills and balance during cancer therapy (Reinders-Messelink et al.,
1999). Additionally, assessment of gross motor skills with a novel measure of gross motor
functioning revealed pediatric ALL patients treated with chemotherapy and radiation had
reduced motor performance in muscular strength, handgrip strength, muscular endurance in legs,
hand eye coordination, static balance, speed, and flexibility (Gotte et al., 2015).
In addition to observing gross motor impairments during cancer therapy, gross motor
deficits may persist through remission for pediatric ALL survivors. At the termination of cancer
therapy, children treated for ALL with radiation and chemotherapy have displayed significant
gross motor deficits with 60% of an ALL sample displaying gross motor impairments (HarilaSaari, Huuskonen, Tolonen, Vainionpaa, & Lanning, 2001). Within a year following treatment
cessation, pediatric ALL survivors have displayed persisting gross motor impairments, including
agility, coordination, balance, reaction time, running and limb speed (Hartman, van den Bos,
Stijnen, & Pieters, 2006; Leone et al., 2014; Wright, Halton, Martin, & Barr, 1998). This has
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included older cohorts treated with chemotherapy and radiation (Wright et al., 1998) as well as
younger cohorts treated with chemotherapy only (Hartman et al., 2006; Leone et al., 2014).
Results from several studies suggests gross motor impairments on tasks such as ball
skills, ankle dorsiflexion, grip strength, endurance, coordination, side galloping and throwing
may be evident up to five years post treatment cessation in pediatric ALL survivors treated with
chemotherapy and radiation (Beulertz, Bloch, Prokop, & Baumann, 2013; Hartman, van den Bos,
Stijnen, & Pieters, 2008; Naumann et al., 2015; Wright, Galea, & Barr, 2005) as well as those
treated with only chemotherapy (Van Brussel et al., 2006; Reinders-Messelink et al., 1996). In
contrast, assessment of gross motor skills using the Bruininks-Oseretsky Test of Motor
Proficiency (BOT) revealed no significant impairments in gross motor functioning in ALL
survivors treated with only chemotherapy seven years after treatment cessation with only five
percent of the sample falling within the below average range in gross motor skills (Ramchandren
et al., 2009). Inconsistencies in findings may be related to the different assessments used to
measure gross motor skills. Overall, available evidence suggests gross motor impairments are
present during treatment in pediatric ALL patients treated with radiation and chemotherapy, as
well as in those treated with only chemotherapy; however, due to limited evidence and
inconsistencies in findings, it is not clear whether gross motor impairments are long-term late
effects for pediatric ALL survivors. Therefore, further research is needed to investigate the longterm trajectory of gross motor impairment in the survivor population.
2.3 Fine Motor
Impairments in fine motor skills in children diagnosed with ALL have also been reported.
Within the pediatric oncology literature, fine motor skills have been measured in a variety of
ways, including pegboard tasks, finger tapping, hand speed/accuracy, trail tracing tasks, and
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handwriting (Green et al., 2013). Similar to gross motor skills, fine motor deficits have been
observed during the course of cancer therapy, though the findings are mixed. Several studies
revealed pediatric ALL patients treated with only chemotherapy display significantly impaired
fine motor abilities during treatment compared to normative samples (Copeland et al., 1988;
Dowell, Copeland, & Judd, 1989, Hockenberry et al., 2007; Sabarre, Rassekh, & Zwicker, 2014)
and healthy controls (Reinders-Messelink et al., 1999). Impairment was evident on pegboard,
finger tapping, trail tracing, and hand speed/accuracy tasks. Additionally, results from an
assessment of handwriting movements revealed pediatric ALL patients treated with only
chemotherapy had significantly more handwriting problems, such as writing more slowly and
using greater pressure, compared to healthy controls (Reinders-Messelink et al., 2001).
Alternatively, several studies have suggested fine motor skills, as measured by tapping and
pegboard tasks, remain intact throughout cancer therapy in pediatric ALL patients treated with
only chemotherapy (Copeland, Moore, Francis, Jaffe, & Culbert, 1996; Jansen et al., 2005). Of
note, the assessments used to measure fine motor skills are inconsistent across the literature,
which may contribute to the variable findings. Regardless, research suggests fine motor abilities
may be impaired during treatment in pediatric ALL patients treated with only chemotherapy.
Similarly, findings are mixed with regard to fine motor functioning in pediatric ALL
patients following treatment. In a meta-analysis on pediatric ALL survivors treated with only
chemotherapy, Peterson and colleagues (2008) found that fine motor functioning was variable;
deficits were evident on the purdue pegboard task, including dominant and non-dominant hands,
while ALL survivors performed better than healthy controls on a finger tapping task. The results
from several post-treatment cross-sectional studies suggested fine motor abilities, as measured by
pegboard, finger tapping, and other manual dexterity tasks, were significantly impaired in
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pediatric ALL survivors treated with chemotherapy and radiation (Edelmann et al., 2014; Harila,
Winqvist, Lanning, Bloigu, & Harila-Saari, 2009) as well in samples treated with only
chemotherapy (Copeland et al., 1988; Harila-Saari, Huuskonen, Tolonen, Vainionpaa, &
Lanning, 2001; Hartman et al., 2006; Hockenberry et al., 2007; Jansen et al., 2008; Kaemingk,
Carey, Moore, Herzer, & Hutter, 2004; Kingma et al., 2001) compared to healthy controls. These
findings have been reported in survivors ranging from one to twenty years since diagnosis of
ALL (Harila, 2009; Hartman et al., 2006). Alternatively, Van Brussel and colleagues (2006)
found that child ALL survivors treated with only chemotherapy performed within the normative
range on manual dexterity tasks compared to healthy controls five years after treatment
cessation, as measured by the MABC.
Longitudinal data suggest fine motor deficits observed during treatment persist and
possibly worsen years following treatment cessation in pediatric ALL patients treated with only
chemotherapy (Copeland et al., 1988; Jansen et al., 2008; Kingma et al., 2001). These findings
contradict research suggesting that fine motor deficits developed during treatment in pediatric
ALL patients treated with only chemotherapy but improved following treatment cessation
(Copeland et al., 1996; Dowell et al., 1989; Hockenberry et al., 2007). Also, as previously
mentioned, patients treated with only chemotherapy reportedly experience impairments in
writing abilities while undergoing treatment; however, alternative findings suggest ALL
survivors have intact writing abilities three to six years following treatment cessation (Hartman,
van den Bos, Dartel, Stijnen, & Pieters, 2007). Assessment and research design variations may
explain the inconsistent results across the fine motor literature. Nevertheless, considering that
weaknesses in fine motor abilities have been observed, further research is needed to fully
characterize the presentation of fine motor deficits in pediatric ALL patients.
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2.4 Visual-Motor
Impairments in visual-motor functioning have also been observed in children treated for
ALL. Visual-motor functioning includes the ability to accurately perceive and coordinate visual
information to produce motor output, such as copying figures (Anderson & Kunin-Batson,
2009). The Beery Buktenica Developmental Test of Visual Motor Integration (VMI) is the most
commonly used assessment of visual-motor abilities in pediatric oncology research, which
requires children to replicate and draw simple figures (Green et al., 2013). Studies assessing ontreatment visual-motor functioning using the VMI have revealed generally average performance
in pediatric ALL patients treated with only chemotherapy (Brown et al., 1992; Copeland et al.,
1988; Copeland et al., 1996; Dowell et al., 1989; Espy et al., 2001; Hockenberry et al., 2007;
Krappmann, Paulides, Stohr, Ittner, & Plattig, 2007). Therefore, it appears that visual-motor
skills may be intact during the medical treatment phase.
Off-treatment studies, however, revealed mixed findings with regard to the trajectory of
visual-motor functioning (Green et al., 2013). Results from cross-sectional studies revealed
children with ALL treated with only chemotherapy performed significantly worse on the VMI
compared to healthy controls and normative ranges when assessed one to seven years following
treatment cessation (Brown et al., 1998; Kaemingk et al., 2004; Knight, McCarthy, Anderson,
Hutchinson, & De Luca, 2014). In addition, pediatric ALL survivors treated with only
chemotherapy displayed poor performance on a computerized visual-motor test battery compared
to healthy controls after ending treatment (Buizer, de Sonneville, van den Heuvel-Eibrink,
Njiokiktjien, & Veerman, 2005). Notably, patients displayed the greatest amount of impairment
on the most complex task (pursuit task), which required a higher level of cognitive control
(Buizer et al., 2005).
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Findings from longitudinal studies are variable. Four longitudinal studies revealed no
significant differences in performance on the VMI in pediatric ALL patients treated with only
chemotherapy during treatment when compared to performance at various times following
cancer therapy (Copeland et al., 1988; Dowell et al., 1989; Hockenberry et al., 2007; Krappmann
et al., 2007). In contrast, four alternative studies showed visual-motor functioning progressively
declined on the VMI one to 11 years following treatment termination in pediatric ALL survivors
treated with chemotherapy and radiation (Brown et al., 1992) and samples treated with only
chemotherapy (Copeland et al., 1996; Espy et al., 2001; Kingma et al., 2001). In a study by
Jansen and colleagues (2008), pediatric ALL survivors treated with only chemotherapy
performed significantly worse on the VMI three years after diagnosis compared to their
performance at diagnosis. Also, they displayed a significant decline four years after treatment on
the Rey Complex Figure Test, a more complex visual-motor copying task (Jansen et al., 2008). A
similar pattern has emerged in the pediatric oncology literature for visual-motor functioning as
seen for fine motor and gross motor skills, in that empirical evidence is variable with regard to
visual-motor functioning and further studies are needed to clarify the presentation and trajectory
of the impairment.
2.5 Motor Adaptation
Given that children with ALL display a wide range of motor deficits, it is possible that
survivors also experience deficits in motor learning and the ability to adjust their movements
according to their environment. Moreover, it is possible that one of the underlying processes of
motor functioning is impaired. According to computational models of motor functioning, there
are a variety of processes that underlie successful motor movement (Gowen & Hamilton, 2012;
Wolpert, 1997; Wolpert & Ghahramani, 2000). First, sensory information, including inputs from
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the visual and proprioceptive systems, is consolidated into a state estimation (e.g., body relative
to stimuli and environment). Then, the current state is compared to the desired state and an
inverse model (e.g., planning how to convert sequence of motor commands into movement goal)
is developed, followed by execution of the motor command. Additionally, a forward model sends
a copy of the motor command prior to execution to the state estimation to make a prediction of
the expected sensory input. In order to better understand the underlying processes of motor
functioning, motor learning needs to be further assessed.
Motor learning occurs as a result of changes in internal motor processes following
practice and experience, which determine whether a person can execute motor actions (Schmidt
& Wrisberg, 2008). One specific aspect of motor learning is sensorimotor adaptation, which is
the ability to adjust motor movements to reflect alterations in the environment (Willingham,
1998). Successful sensorimotor adaptation is critical for efficient execution of higher-order
motor functions, as well as for activities of daily living, academic performance, and cognitive
functioning (Kirby, Sugden, Edwards, 2010; Zoia, Barnet, Wilson, & Hill, 2006). Unfortunately,
there have been no studies that directly targeted the issue of motor learning in pediatric ALL.
Based on the computational model of motor functioning (Gowen & Hamilton, 2012), motor
learning deficits could be a significant contributor of observed motor deficits in pediatric ALL
survivors; therefore, it is critical to further assess motor learning in child ALL survivors.
2.6 Motor-Related Academic and Psychosocial Outcomes
Evidence from a breadth of empirical studies indicate children with ALL display poorer
performance on various motor tasks during treatment and remission; however, there is limited
understanding as to how these motor impairments relate to one another as well as with other
domains of functioning, such as academic and psychosocial, within the pediatric oncology
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population. White matter models have been used within non-medical populations to explain the
presentation of nonverbal learning disabilities (NLD; Rourke, 2002). NLD is characterized by
impairments in visual-spatial, motor, and social skills (Rourke, 2002). The white matter models
suggest that deficits in visual-motor construction are secondary to primary deficits in fine motor
functioning and spatial perception (Rourke, 2002). Further, tertiary deficits in higher-level
cognitive skills, such as difficulties in arithmetic and social communication, may result from
difficulties in the primary and secondary level skills (Rourke, 2002). The severity of white matter
damage justifies the NLD phenotype, or the amount of difficulty across the primary, secondary,
and tertiary skills (Rourke, 2002). Although NLD is not currently recognized as a DSM-5
disorder, the white matter models presumed to underlie NLD have been utilized in research
related to other DSM-5 neurodevelopmental disorders, such as autism (Semrud-Clikeman, Fine,
& Bledsoe, 2014; Williams, Goldstein, Kojkowski, & Minshew, 2008).
White matter models have also been utilized to conceptualize late effects in patients
treated for brain tumors and ALL with chemotherapy and without radiation (Carey, Barakat,
Foley, Gyato, & Phillips, 2001; Carey et al., 2007; Hockenberry et al., 2007). Carey and
colleagues (2007) found that ALL and brain tumor survivors had lower performance on tasks
assessing visual-constructional skills and achievement, as well as increased concerns of social
difficulties and internalizing symptoms compared to healthy controls, which is consistent with
NLD. Knight and colleagues (2014) later assessed the relationship between fine motor and
visual-motor skills in pediatric ALL survivors treated with only chemotherapy and found no
significant relationship. The authors note that although fine motor skills may underlie visualmotor abilities in typically developing children, deficits in other cognitive functions may better
account for visual-motor deficits in children with ALL (Knight et al., 2014). Notably, Knight and
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colleague’s (2014) study assessed ALL survivors after medical treatment. It is possible that the
relationship between fine motor and visual-motor functioning varies in ALL patients dependent
upon the time of the evaluation. Nonetheless, future research is needed to fully understand the
relationship between these two components of motor functioning.
When considering math weaknesses, Kaemingk and colleagues (2004) investigated the
relationship between math performance with other domains of neurocognitive functioning,
including fine motor (Purdue Pegboard) and visual motor (Beery VMI), in a sample of pediatric
ALL survivors treated with only chemotherapy compared to healthy controls. Results revealed
dominant hand psychomotor speed significantly related to math performance in the ALL group
and visual-motor functioning significantly related to math performance in the control group
(Kaemingk et al., 2004). Alternatively, recent findings revealed visuomotor functioning was
significantly correlated with academic functioning, specifically math calculation, in pediatric
ALL survivors treated with only chemotherapy (Balsamo et al., 2015; Moore et al., 2016). These
results are consistent with significant correlations observed between motor functioning and
academic abilities in healthy children as well as other clinical populations (Cummins, Piek, &
Dyck, 2005; Davis, Pitchford, & Limback, 2011; Piek, Dawson, Smith, & Gasson, 2008). Taken
together, these results suggest academic deficits may be secondary to motor impairments (Butler
& Mulhern, 2005; Kaemingk et al, 2004).
Similarly, motor difficulties can interfere with children’s day-to-day functioning and
interaction with their environment (Cummins et al., 2005; Green et al., 2013). Moreover,
children with motor deficits have displayed social impairments and emotional disturbances
related to motor functioning (Cummins et al., 2005). Long-term survivors of pediatric ALL
reportedly experience significantly greater depression and somatization than healthy siblings
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(Zebrack et al., 2002). However, the relationship between psychosocial late effects and motor
functioning has yet to be studied in the pediatric ALL population. As such, further research is
needed to understand how treatment-related motor deficits in pediatric ALL relate to other
neurocognitive and psychosocial outcomes.
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Chapter 3: Etiology of Motor Impairments
Motor impairments, along with other neurocognitive late effects, observed in pediatric
ALL suggest that lifesaving treatment may come at a cost. Historically, intensive ALL treatment
included a combination of cranial radiation therapy (CRT) and chemotherapy; however, as
research revealed treatment related adverse cognitive effects, CRT was removed from most
treatment protocols (Butler & Mulhern, 2005; Moleski, 2000). Modern treatment regimens
typically include approximately 30 weeks of medical interventions incorporating a combination
of systemic chemotherapy and intrathecal (IT) chemotherapy, with CRT used minimally for
high-risk ALL cases (Moleski, 2000). Although researchers have adjusted treatment protocols to
reduce neurotoxicity, adverse treatment related side effects still arise due to the impact of
treatment on the developing brain including atrophy to gray matter or degeneration of white
matter (e.g., leukoencephalopathy; Moore, 2005; Saykin, Ahles, McDonald, 2003). The
following reviews the etiology of motor deficits in ALL with emphasis on treatment induced
pathophysiological factors.
3.1 Physical Activity
Pediatric ALL survivors often experience alterations in physiological outcomes related to
physical functioning, such as weight, body mass index, height, and blood pressure (Ness,
Armenian, Kadan-Lottick, & Gurney, 2011). From treatment onset to six years following
treatment cessation, reported prevalence of weight gain and obesity is significantly greater for
children treated for ALL compared to normative samples and healthy controls (Atkinson et al.,
2015; Baillargeon et al., 2007; Breene, Williams, Gattens, Acerini, & Murray, 2011; Bruzzi et
al., 2014; Chow, Pihoker, Hunt, Wilkinson, & Friedman, 2007; Esbenshade et al., 2011; Harper,
Breene, Gattens, Williams & Murray, 2013; Hartman et al., 2012; Oeffinger et al., 2003). In
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addition to weight, changes have also been observed in height with lower heights reported for
patients following treatment compared to heights reported during treatment (Breene et al., 2011;
Bruzzi et al., 2014; Hovi et al., 1993). Exposure to radiation therapy, which is less common in
current treatment protocols, has been identified as a risk factor for decreased height and
increased weight and BMI (Oeffinger et al., 2003); however, more recent studies with only
chemotherapy samples have also reported significant changes in ALL survivors’ weight, height,
and BMI (Atkinson et al., 2015; Bruzzi et al., 2014). The combination of decreased physical
activity and increased weight subjects survivors of pediatric ALL to a higher risk of metabolic
syndrome, which may lead to an increased risk of medical conditions later in life, such as heart
disease, stroke, and diabetes (Harper et al., 2013). Together, changes in height and weight may
impact the motor functioning and long-term health of children with ALL.
Treatment-induced metabolic, respiratory, and cardiovascular changes have been
considered primary factors affecting physical function and obesity in childhood ALL (Iughetti et
al., 2012). Moreover, children with ALL treated with radiation therapy often experience
hypothalamic-pituitary axis damage from medical treatment resulting in changes in growth
hormone production (Iughetti et al., 2012). Such metabolic changes may explain the alterations
in height and weight observed in pediatric ALL when patients are treated with radiation.
Additionally, cyclophosphamide, a chemotherapy agent, can reduce lung capacity, resulting in
decreased physical functioning (Jarvela et al., 2010). In a diagnostically heterogeneous sample
(28% ALL) of children treated (62% chemotherapy only) for cancer, poor cardiorespiratory
fitness was indicated both during and after treatment and was significantly associated with levels
of physical activity and older age, but not treatment type (Braam et al., 2015). Similarly,
anthracycline, another chemotherapy agent, is associated with cardiac late effects, which may
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impair long-term physical functioning (Ness et al., 2011). Taken together, radiation therapy can
induce metabolic changes and chemotherapy can result in respiratory and cardiac concerns,
which can all contribute to physical fitness and weight changes during and following treatment.
Lifestyle modifications observed in pediatric ALL may also contribute to changes in
physical functioning. Children with ALL often develop a sedentary lifestyle as habitual physical
activity levels decrease throughout treatment (Iughetti et al., 2012; Leone et al., 2014). Research
suggests that reduced exercise capacity and motor functioning, decreased personal interest in
physical activity, and overprotective caregivers may contribute to decreased physical activity in
ALL patients (Iughetti et al., 2012). Moreover, Cox and colleagues (2009) developed an
interaction model indicating predictors such as fear, motivation, affect, fatigue, and pain may
impact physical activities in survivors of childhood cancer. Also, a sample of adolescent ALL
patients reported fatigue and pain were major reasons for avoiding physical activity (Wright,
2015). Overall, the cause of decreased physical activity and increased weight gain in pediatric
ALL is likely multifaceted including lifestyle, metabolic, and physical changes, which are
treatment dependent and may bidirectionally influence each other.
3.2 Gross Motor
Cancer therapy can also negatively impact the CNS resulting in gross motor skill deficits
(Dewey, Bottos, & Tupper, 2004). Research suggests chemotherapy (e.g., methotrexate and
vincristine) and CRT both contribute to structural changes in brain regions associated with motor
functioning (Dewey et al., 2004). Moreover, significant leukoencephalopathy (e.g.,
demyelination or damage to white matter) has been observed in the motor pathways of pediatric
ALL patients with notable deficits in gross motor skills following cancer therapy (Harila-Saari et
al., 1998; Harila-Saari et al., 2001). In a sample of ALL survivors with mixed-treatment
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protocols (e.g., chemotherapy only, radiation only, both), chemotherapy agents, including
vincristine and methotrexate, as well as radiation, were associated with axonal injury in the
motor pathway (Harila-Saari et al., 1998). Alternatively, in another mixed-treatment ALL
sample, motor evoked potential (MEP) latencies within the motor pathway were associated with
the number of doses of intrathecal methotrexate; however, no significant association was found
between MEP latencies and whether or not patients received radiation therapy (Harila-Saari et
al., 2001), suggesting both radiation and chemotherapy may both contribute to motor pathway
alterations. Of note, myelination of the motor pathway, including peripheral motor nerves and
fibers between basal ganglia and the cortex (i.e., frontal lobe) are critical during motor
development in childhood; therefore, treatment induced leukoencephalopathy may explain
observed gross motor deficits in ALL patients (Moleski, 2000). In addition leukoencephalopathy
impacts posterior, parietal regions in addition to frontal regions (Shin, Stern, Janss, Hunter &
Liu, 2001). The parietal lobe is also critical for successful motor execution (Fogassi & Luppino,
2005). Therefore, damage to the parietal region may explain observed gross motor impairments
in the pediatric ALL population.
Steroids are also a common part of ALL treatment regimens (Ness et al., 2011). In a
sample of patients with non-Hodgkin’s lymphoma, motor weakness due to both neuropathy and
myopathy were related to not only vincristine, but corticosteroid (e.g., dexamethasone) as well
(DeAngelis, Gnecco, Taylor, & Warrell, 1991). Therefore, steroid-induced neuropathy induced
muscle weaknesses may also account for gross motor deficits. Additionally, it has been
suggested that higher rates of obesity and risk for metabolic syndrome in pediatric ALL patients,
induced by treatment, may also contribute to weaknesses in gross motor functioning (Atkinson et
al., 2015; Harper et al., 2013).
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From an environmental and psychosocial perspective, impairments in gross motor
functioning may be related to lifestyle alterations during ALL treatment (Leone et al., 2014).
Moreover, a treatment induced sedentary lifestyle may result in fewer opportunities to engage in
motor activities. Therefore, pediatric oncology patients may have less opportunity to engage in
organized sports or play/interact with their peers. Decreased physical activity and engagement in
motor activities may inhibit gross motor development in children with ALL (Leone et al., 2014).
Taken together, treatment related lifestyle changes in conjunction with CNS alterations may
contribute to decreased gross motor skills in pediatric ALL.
3.3 Fine Motor
Treatment effects have also been associated with impaired fine motor skills. Specifically,
research has primarily focused on the adverse effects of vincristine on fine motor functioning
(DeAngelis et al., 1991; Dewey et al., 2004). Moreover, vincristine-induced neuropathy is
frequently reported in ALL patients without radiation therapy and has been identified as a
primary cause of fine motor deficits (Jain et al., 2013; Quasthoff & Hartung, 2002). Additionally,
in a sample of childhood survivors of medulloblastoma and ALL treated with varying doses of
methotrexate without radiation, results revealed decreases in white matter fractional anisotropy
were associated with fine motor speed (Aukema et al., 2009). Research suggests damage
produced by methotrexate may be reversible as white matter changes dissipate in follow up
evaluations of ALL patients; however, vincristine induced neuropathy is long-lasting requiring
considerable regeneration (Copeland et al., 1988; Lehtinen et al., 2002; Vezmar, Becker, Bode,
& Jaehde, 2003). These mechanisms may account for reported improvement in gross motor
functioning (e.g., structural improvements in white matter tracts) and persisting fine motor
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deficits (e.g., long-lasting neuropathy) following ALL treatment (Lehtinen et al., 2002;
Ramchandren et al., 2009).
Comparable to gross motor skills, treatment induced lifestyle changes, including school
absence and limited opportunities to practice motor skills, may also contribute to delays in fine
motor development in ALL patients (Green et al., 2013). Fine motor development is fostered
through school activities, such as handwriting, keyboarding, crafts, and music; however, children
with ALL may miss these opportunities due to medical treatment. Additionally, the behavioral
manifestation of other neurocognitive late effects may contribute to fine motor deficits. For
instance, pediatric ALL survivors experience significant declines in information processing
compared to healthy controls due to CNS damage from treatment (Mennes et al., 2005).
Similarly, processing speed difficulties may also contribute to fine motor delays in ALL patients
(Jansen et al., 2008). In all, cancer treatment and lifestyle factors may contribute to observed fine
motor impairments in pediatric ALL.
3.4 Visual-Motor
Chemotherapy, specifically methotrexate, has been associated with impaired visual-motor
functioning in pediatric ALL patients treated with chemotherapy only (Carey et al., 2007; Knight
et al., 2014). It is hypothesized that methotrexate impacts cerebellar-frontal functioning given
that ALL patients treated with chemotherapy have displayed significant reductions in these
regions (Abe & Hanakawa, 2009; Lesnik et al., 1998; Mahone et al., 2007). Damage to these
regions results in deficits in visual-motor organization, motor timing, and visual-spatial attention,
which are critical skills for efficient visual-motor functioning (Lesnik et al., 1998; Mahone et al.,
2007). Parietal lobe functioning has also been associated with visual-motor skills in clinical
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populations; however, further analysis is needed to assess the correlations between parietal lobe
impairment and visual-motor functioning in ALL patients (Kashiwagi & Tamai, 2013).
3.5 Associations Between Motor Skills and Academic/Psychosocial Functioning
Research on the neurological underpinnings of the relationship between motor
functioning with other domains of functioning may be helpful in understanding how these skills
relate within the pediatric ALL population. The interrelation between motor and cognitive
functioning has been supported by neuroimaging data revealing intimate connections between
relevant brain regions. For instance, a major function of the pre-motor area is transferring
sensory information to motor output regions, such as the primary motor area; however, imaging
data suggest the dorsal premotor cortex (PMd) also interacts with the dorsolateral prefrontal
cortex (dlPFC), which is involved with cognitive functioning and attention selection (Abe &
Hanakawa, 2009). The transformation of sensory input in the PMd to cognitive information in
the dlPFC supports pre-movement processing (Abe & Hanakawa, 2009). Similarly, imaging has
revealed the cerebellum and the dlPFC function in a circuit and are both heavily recruited when
attention and concentration are required to learn novel tasks, both cognitive and motor
(Diamond, 2000). Also, the caudate, an output region for the dlPFC, contributes to both
cognitive and motor functioning (Diamond, 2000). In all, prefrontal regions in conjunction with
cortical and subcortical motor regions subserve both motor and cognitive functioning, which
may further explain the association between these skills.
Treatment with corticosteroids may also explain comorbid impairments in academic and
motor functioning. Specifically, corticosteroids, such as dexamethasone and prednisone, are
often incorporated in treatment protocols for pediatric ALL patients (Kadan-Lottick et al., 2009).
However, corticosteroids have been identified as a potential causal agent for learning and motor
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late effects across a variety of pediatric populations, including leukemia, chronic lung disease,
and cancer (Kadan-Lottick et al., 2009). The aversive impact of corticosteroids on academic
functioning and learning may be explained by hippocampal structural changes induced by
corticosteroids (Brown, 2009).
As previously mentioned, white matter models have been utilized to conceptualize the
subset of symptoms known as NLD, including motor, visuo-spatial, and social difficulties
(Rourke, 2002). White matter models suggest that white matter, or myelinated fibers, are
damaged due to developmental issues as well as acute neurological conditions (e.g., head injury)
(Rourke, 2002). Damage localized to the right hemisphere is presumed to be the primary cause
of the disorder, given the heavy involvement of the right hemisphere in visual-spatial skills
(Rourke, 2002). From this perspective, it may be presumed that damage to white matter fibers in
the right-hemisphere following ALL treatment may explain the observed deficits in motor within
this population, as well as the resulting impairments in academic functioning and psychosocial
impairments. Focused research assessing white matter integrity along with neurocognitive skills
consistent with the white matter model (e.g., motor skills, academic) is needed to fully
understand how the white matter model may be applied to the ALL survivor population.
In addition, white matter models may justify the relationship between motor impairments
and psychosocial functioning in children with ALL (Rourke, 2002). As previously mentioned,
difficulties in social communication may arise tertiary to primary and secondary deficits in motor
functioning (Hockenberry, 2007). It has been suggested that deficits in motor functioning impede
a child’s ability to appropriately engage in their physical and social environment (Green et al.,
2013). Therefore, children may develop psychosocial deficits, such as impaired communication
or affective symptoms, secondary to motor impairments. As motor research within pediatric
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oncology progresses it will be important for researchers to also consider the relationship between
psychosocial functioning and motor skills.
3.6 Motor Adaptation
As previously mentioned, it can be hypothesized that children treated for ALL may also
experience impairments in motor learning given the other observed motor deficits in this
population. Furthermore, the neurotoxicity of ALL treatment may also impair brain regions
necessary for efficient motor learning and adaptation. For instance, the cerebellum plays a
primary role in motor learning and adaptation (Izawa, Criscimagna-Hemminger, & Shadmehr,
2012). Children treated with chemotherapy for ALL often experience treatment-related
cerebellar damage (Leznik, Ciesielski, Hart, Benzel, & Sanders, 1998). Studies using animal
models have also suggested methotrexate can have an oxidative and detrimental impact on rat
cerebellums (Sugiyama, Sun, Ueda, Furukawa, & Takeuchi, 2015; Uzar et al., 2006). As noted,
treatment for ALL may also result in impairment to the parietal lobe (Kashiwagi & Tamai, 2013)
and diffuse white matter damage (Aukema et al., 2009), which may also result in poor motor
learning and adaptation. In all, treatment related neurological changes can contribute to potential
impairments in motor learning and adaptation in the survivor population.
3.7 Risk Factors
Research assessing motor functioning of ALL patients is still novel, yet several studies
have identified client and treatment related risk factors. The patient’s sex has consistently been
reported as a risk factor for various motor outcomes. Female ALL patients are at a higher risk for
obesity (Breene et al., 2011; Bruzi et al., 2014; Harper et al., 2013), decreased physical fitness
(Jarvela et al., 2010), and visual-motor deficits (Brown et al., 1998) compared to male patients.
Additionally, race or ethnicity has been identified as a risk factor for obesity in pediatric ALL
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patients with Black and Hispanic patients at increased risk (Withycombe et al., 2009). No race or
ethnicity risk factors have been identified for motor functioning in pediatric ALL. Finally,
individual differences in brain reserve capacity may influence the manifestation of motor
symptoms (Mulhern & Palmer, 2003; Satz, 1993). Pediatric ALL patients with higher thresholds
for brain damage, or neurotoxicity from chemotherapy, may display fewer motor deficits as
compared to individuals with low reserve capacity (Mulhern & Palmer, 2003).
Treatment related risk factors may also contribute to motor delays in the pediatric ALL
population. Exposure to higher doses of chemotherapy agents and corticosteroids are at higher
risk for developing obesity (Chow et al., 2007), decreased muscle strength (Hovi et al., 1993),
fine motor deficits (Kingma et al., 2001), and visual-motor skill deficits (Buizer et al., 2005;
Carey et al., 2007; Copeland et al., 1996). Additionally, younger age at diagnosis (Baillargeon et
al., 2007; Buizer et al., 2005) and treatment (Bradlyn et al., 1996; Copeland et al., 1996; Kingma
et al., 2001), when age is measured as continuous variable, are associated with weight gain and
motor deficits in pediatric ALL patients. Genetic factors may also increase a patient’s
susceptibility to treatment related motor late effects (Ahles et al., 2003; Hartman et al., 2010). In
combination, these treatment and demographic factors may increase the likelihood of pediatric
ALL survivors developing motor related late effects.
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Chapter 4: Assessing Motor Functioning
Empirical evidence has consistently identified motor deficits in pediatric ALL
populations; as a result, efficient motor assessments are necessary to accurately identify motor
impairments to inform interventions. However, the pediatric ALL population is unique and
medically complicated. Therefore, researchers have contemplated the feasibility of conducting
motor assessments with this population (Jansen et al., 2005). Moreover, ALL patients undergo
intensive treatment that can lead to significant pain, osteonecrosis, and limited range of motion,
which may contribute to variability observed in motor functioning (Hartman et al., 2006;
Marchese et al., 2008). Nonetheless, empirical evidence suggests that conducting
neuropsychological assessments, including motor measures, is feasible during medical treatment,
including at treatment onset (Jansen et al., 2008). Qualitative reports also indicate ALL patients
may enjoy completing neuropsychological testing as it is a distraction from the emotionally
taxing medical treatments (Jansen et al., 2008). Despite being a medically complicated
population, researchers, with the use of precaution regarding pain and osteonecrosis, can conduct
feasible, and potentially enjoyable, motor assessments with pediatric ALL patients.
4.1 Measuring Motor Functioning
Across the pediatric oncology literature a variety of motor assessments have been
selected to assess motor skills. In general performance based measures have been used, which
consist of broad as well as specific motor tasks. Additionally, self-report measures have been
used to obtain the patient’s perspective of motor functioning. The following reviews both
performance and self-report motor assessments utilized in pediatric oncology literature.
Gross motor. When considering assessment tools for measuring gross motor skills, the
administrative aspects and content areas assessed should be reviewed. Moreover, Cools (2009)
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identified several important factors to be considered. For instance, the gross motor measure
should be standardized, have simple testing instructions, and provide clear descriptions of the
testing environment needed (Cools et al., 2009). Also, the measure should assess the main
content areas of gross motor functioning, including locomotion, object control, and stability
(Cools et al., 2009). Within pediatric oncology research, various measures have been used to
assess gross motor functioning. One of the most frequently utilized measures of gross motor
functioning in pediatric oncology has been the Movement Assessment Battery for Children
(MABC), which meets the basic criteria of a gross motor measure (Green et al., 2013;
Henderson, Sugden, & Barnett, 2007; Sabarre et al., 2014).
The MABC has been used extensively within clinical settings to assess suspected
Developmental Coordination Disorder and other motor concerns (Venetsanou et al., 2011).
Historically, researchers and clinicians used the MABC; however, recent research has adopted
the second edition of the MABC (Sabarre et al., 2014). Although this version is generally
consistent with the first version, the psychometric properties are still limited (Brown & Lalor,
2009) and the structural validity has been questioned for younger children (Schulz, Henderson,
Sugden, & Barnett, 2011; Wagner, Kastner, Petermann, & Bos, 2011). Nonetheless, the MABC2 has displayed adequate reliability and sensitivity to motor disorders and continues to be
frequently used for empirical studies in pediatric oncology.
Most measures used to assess motor functioning in pediatric oncology populations have
normative samples with healthy, typically developing children. However, a novel assessment has
been developed recently to assess motor functioning in this specific patient group (Gotte et al.,
2013). The MOON-test (test for motor performance in the oncology) was developed by German
researchers who were interested in creating a diagnostic tool that could be routinely used in
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oncology clinics (Gotte et al., 2013). The measure consists of 8 items assessing four domains of
motor abilities: strength, speed, coordination, and flexibility. Gotte and colleagues’ (2013)
original study used the MOON-test to assess a small sample (n=33) of children diagnosed with
various types of cancer and found the MOON-test displayed general acceptance and high
feasibility within the oncology population. As the MOON-test has only been utilized in three
studies, the psychometrics are limited (Gotte et al., 2013; Gotte, Kesting, Winter, Rosenbaum, &
Boos, 2015; Kesting, Gotte, Seidel, Rosenbaum, & Boos, 2015) Nonetheless, this measure offers
an opportunity for future researchers and clinicians to specifically study and compare the
performance of motor abilities across the pediatric oncology population. For the present study,
the MABC was utilized to measure gross motor functioning considering its wide use with both
typically developing children and pediatric ALL survivors.
Fine motor. Similar to gross motor skills, specific assessments have been developed to
independently measure fine motor abilities. For instance, pegboard tasks have been used
frequently to assess fine motor functioning. The Purdue Pegboard has been used extensively to
assess motor coordination, including within the pediatric oncology population and has displayed
solid psychometric properties (Hockenberry et al., 2007; Jansen et al., 2008; Kaemingk et al.,
2004; Kingma et al., 2001; Yancosek & Howell, 2009). Additionally, the Grooved Pegboard Test
has also been used to assess fine motor functioning in children with ALL (Edelmann et al., 2014;
Harila et al., 2009). Taken together, the Grooved Pegboard and Purdue Pegboard test may both
be utilized within the pediatric oncology population given their historical use in research
(Yancosek & Howell, 2009).
Finger-tapping tasks are another common way to assess fine motor functioning,
specifically motor-speed. The Finger Tapping Test, which was originally a part of a larger
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neuropsychological battery called the Halstead-Reitan battery, is a test of motor speed using a
standardized mechanical counting apparatus (Morrison, Gregory, & Paul, 1979). Psychometric
data are limited for the Finger Tapping Test due to its incorporation in other neuropsychological
batteries; however, the Finger Tapping Test has displayed good discriminant abilities within
populations with motor dysfunctions caused by cerebellar, basal ganglia, and cerebral damage
(Shimoyama, Ninchoji, & Uemura, 1990). Computerized finger tapping paradigms have also
been employed to assess fine motor functioning (Mahone, Prahme, Ruble, Mostofsky, &
Schwartz, 2007). For instance, participants in Mahone and colleagues study were instructed to
tap a button in response to computer tones in one trial and continue tapping at the same rate in an
unguided trial. In addition to fine motor abilities, the unguided trial of this assessment allows for
the evaluation of cerebellar functioning and perceptual motor timing abilities (Mahone et al.,
2007).
Handwriting and drawing abilities are considered fine motor skills in children, with
particular importance in academic settings (McHale & Cermak, 1992). Of note, handwriting
abilities have also been considered a perceptual motor ability involving complex motor-planning
and perceptual abilities (Feder & Majnemer, 2007). Within the pediatric ALL population,
researchers have used handwriting assessments to measure fine motor abilities. These
measurements included paper and pencil (Hartman et al., 2007) and computerized (ReindersMesselink et al., 1996; Reinders-Messelink et al., 2001) writing assessments. Handwriting
analyses reveal information about the quality of an individual’s writing, including speed,
fluency, pause durations, and pen pressure. Writing analyses are limited within the pediatric ALL
literature and often include non-standardized measures; however, evaluations of writing have
proven to be informative measures of fine motor skills.
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Visual-motor. As previously mentioned, in addition to observing deficits in fine and
gross motor skills, higher order motor skills, such as visual-motor integration, may also be
impaired in pediatric ALL survivors. A common assessment of visual-motor functioning is the
Beery-Buktenica Developmental Test of Visual-Motor Integration (Beery VMI), which requires
the respondent to copy 30 designs with increasing difficulty (Beery & Beery, 2010; Sattler,
2014). The Beery VMI is a clinically and empirically useful measure; however, it should be
noted that this measure has a subjective component in scoring and there are limited
psychometrics for the sixth edition. Nonetheless, the Beery VMI has been used frequently in
pediatric oncology literature to assess visual-motor functioning and proves to be an informative
measure of perceptual-motor abilities (Carey et al., 2007; Espy et al., 2001; Hockenberry et al.,
2007; Jansen et al., 2004; Jansen et al., 2008; Kaemingk et al., 2004).
The Rey-Osterreth Complex Figure Test (RCFT) is another common assessment of
visual-motor skills, though infrequently used within the pediatric oncology population compared
to the Beery VMI (Jansen et al., 2004; Jansen et al., 2008; Waber et al., 1994). The RCFT
requires participants to replicate a figure during a copy trial, which is more complex than the
designs presented in the Beery VMI. Also, the RCFT task includes reproduction trials from
memory, which assess nonverbal memory (Waber et al., 1994). Notably, the Beery VMI is
advantageous due to the fact that norms are available for a broader age range. Regardless, both
the Beery VMI and the RCFT are psychometrically sound measures that have been informative
in assessing visual-motor functioning in ALL patients.
The Beery VMI and RCFT are the most frequently used assessments of visual-motor
functioning in pediatric oncology; however, researchers have also adapted measures from
broader neurocognitive batteries or novel assessments to evaluate visual-motor abilities. For
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instance, when Carey and colleagues (2007) assessed the neuropsychological functioning of
children diagnosed with ALL they combined scores from the Beery VMI and Block Design
subtest of the Wechsler Intelligence Scale for Children (WISC) to derive a nonverbal composite,
which aimed to assess visual-motor abilities. Additionally, an international computerized test
battery of visual-motor function, the Amsterdam Neuropsychological Tasks (ANT), has also
been tested within the pediatric ALL population (Buizer et al., 2005). However, the ANT has
limited psychometric data, particularly within the United States, and has been used infrequently
within the ALL population. Instead researchers and clinicians typically assess visual-motor
functioning using the Beery VMI or RCFT.
Self-reports. In general, objective performance measures are utilized to assess motor
functioning; however, some researchers have also used subjective, self-report measures to assess
the motor skills of pediatric ALL patients (Essig et al., 2014; Gotte et al., 2014; Sabarre et al.,
2014). Self-report motor measures have included child-reported (Gotte et al., 2014) and parentreported forms (Sabarre et al., 2014). Additionally, of the self-report measures utilized within
pediatric ALL research, some have used simple study-specific, non-standardized questionnaires
(Essig et al., 2014), and others have used standardized self-report motor measures, such as the
Movement Assessment Battery for Children-2 Checklist (Sabarre et al., 2014). Another
commonly used child-reported measure of motor movement is the Physical Self-Description
Questionnaire (PSDQ); however, the PSDQ has been infrequently used within the pediatric ALL
motor research to date (Bragado, Hernandez-Lloreda, Sanchez-Bernardos, & Urbano, 2008;
Kennedy, Brown, & Chien, 2012).
Self-report measures of motor functioning offer a unique perspective of a child’s motor
functioning beyond that obtained by performance based measures (Brown, 2012: Kennedy et al.,
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2012). Also, dependent on the rater, self-report measures have displayed moderate to large
correlations with performance-based measures (Kennedy et al., 2012). For instance, parent-report
measures of child motor functioning have displayed moderate correlations with performancebased assessments; however, child-report measures have displayed little to no correlations with
motor performance (Brown, 2012; Kennedy et al., 2012; Sabarre et al., 2014). This may be
related to children typically underestimating their motor functioning (Essig et al., 2014). Childreports also differ from parent-reports in that children focus more on gross motor functioning
than fine motor skills when compared to their parents (Brown, 2012). Also, sex differences may
arise from child-reported motor measures with boys focusing on gross motor functioning and
girls focusing on fine motor activities (Brown, 2012). Due to the variable conclusions with
regard to the utility of self-report motor measures, it has been recommended that clinicians and
researchers utilize self-report measures in conjunction with performance based motor measures
(Kennedy, Brown, & Stagnitti, 2013).
4.2 Measuring Motor Learning
Within the motor literature, there are a variety of ways to measure motor learning;
however, the following study focuses primarily on assessing motor adaptation. Computermanipulated visuomotor adaptation paradigms are one way to assess motor adaptation (Buch,
Young, & Conteras-Vidal, 2003). As previously mentioned, successful motor learning requires
efficiency in various underlying motor processes (e.g., state estimation, forward model
prediction) (Gowen & Hamilton, 2012). When environmental changes occur, these underlying
motor systems need to update (Buch et al., 2003). Moreover, computer-manipulated visuomotor
adaptation paradigms artificially produce environmental changes (e.g., manipulating visual
feedback of hand movements), which alter the relationship between visual feedback on a
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computer screen and hand movements on a manipulandum (e.g., joy stick; Buch et al., 2003).
The impact of these alterations (e.g., after effects) can then be measured. Moreover, individuals
can be presented with baseline trials (e.g., no alterations), followed by a series of experimental
trials with feedback alterations. Thereafter, trials with no alterations can be administered to
assess for motor adaptation from the experimental trails. Overall, computer-manipulated
visuomotor adaptation paradigms offer an opportunity to assess for motor learning in ALL
survivors, which offers a novel assessment of motor functioning in the pediatric oncology
survivor literature and has a potential for future intervention development.
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Chapter 5: Rationale for the Present Study and Proposed Model
Understanding motor functioning in pediatric ALL survivors is a novel component of
ALL late-effect research with ample opportunity for further investigation. Although previous
studies have demonstrated impaired motor functioning in pediatric ALL survivors, the exact
presentation, trajectory, and relationship among these deficits is yet to be thoroughly assessed.
Also, motor learning has yet to be measured within the survivor population. Given the
relationship between motor functioning and other areas of functioning (e.g., academic,
psychosocial) in healthy children as well as ALL survivors, it is also of interest as to how
observed motor impairments in children treated for ALL may relate and/or predict impairment in
other areas. Therefore, the following model is proposed, which postulates that primary deficits in
fine motor functioning and spatial perception proceed secondary deficits in visual-motor
integration, followed by tertiary impairments in academic skills (e.g., spelling and math
computation) and psychosocial functioning (See Figure 1). Together, the present study is
essential for further understanding the motor-related late-effects in children treated for ALL and
will inform future research and intervention studies to improve the quality of life following
medical treatment.
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Figure 1. Proposed model of motor-related late effects. This figure illustrates the progression of
primary treatment related impairments to tertiary deficits and the influence of motor learning
skills on primary and secondary motor functions.
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Chapter 6: Aims of the Present Study
6.1 Specific Aim 1
The first aim focused on characterizing motor functioning of pediatric survivors of acute
lymphoblastic leukemia (ALL) across multiple domains of motor functioning.
•

Hypothesis 1 (a): Survivors of ALL will display significantly lower levels of parentreport physical activity (e.g., engagement in sports activities) and child-report evaluation
of physical self (e.g., PSDQ-S) compared to healthy controls.

•

Hypothesis 1 (b): Survivors of ALL will exhibit significantly poorer gross motor
functioning, as measured by the Movement-ABC, compared to healthy controls.

•

Hypothesis 1 (c): Survivors of ALL will display significantly poorer fine motor
functioning, as measured by both the Movement-ABC and grooved pegboard task,
compared to healthy controls.

•

Hypothesis 1 (d): Survivors of ALL will display significantly lower levels of visualmotor functioning, as measured by the Beery VMI, compared to healthy controls.

•

Hypothesis 1 (e): Survivors of ALL will display significantly lower handwriting
performance, as measured by the Test of Handwriting Skills, compared to healthy
controls.

6.2 Specific Aim 2
The second aim focused on investigating motor learning through a visuomotor adaptation task in
survivors of ALL.
•

Hypothesis 2 (a): Survivors of ALL will display lower motor learning (e.g., smaller
performance change during and smaller aftereffects) on a sensorimotor adaptation task as
compared to healthy controls.
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Hypothesis 2 (b): Motor learning will significantly correlate with fine motor functioning
for survivors of ALL as well as healthy controls.

•

Hypothesis 2 (c): Motor learning will significantly correlate with visual-motor abilities
for survivors of ALL as well as healthy controls.

6.3 Specific Aim 3
The third aim focused on evaluating the associations between multiple domains of motor
functioning (e.g., fine motor, visual-motor) with each other and with both academic and
psychosocial functioning.
•

Hypothesis 3 (a): Visual-spatial skills and fine motor functioning will significantly
correlate with visual-motor functioning in survivors of ALL.

•

Hypothesis 3 (b): Motor functioning will significantly correlate with academic
functioning, including math and spelling performance, as measured by the WRAT-4, in
survivors of ALL

•

Hypothesis 3 (c): Motor functioning will significantly correlate with psychosocial
functioning, as measured by the BASC-3 parent-report Internalizing and Adaptive Skills
composites and associated subscales, as well as with the BASC-3 self-report Internalizing
and Personal Adjustment composites and associated subscales.
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Chapter 7: Research Design and Methodology
7.1 Recruitment
The present study was approved by the institutional review board at Eastern Michigan
University and the Beaumont Health System prior to the onset of data collection. Participants for
the ALL survivor group were recruited through the Pediatric Oncology and Hematology
department at the Beaumont Health System in Royal Oak, Michigan. Medical staff, including a
nurse practitioner and an oncologist, within this department identified eligible participants by
reviewing medical records and discussed the project with families at the ALL survivors’ regular
check-up appointments. After reviewing all eligible participants and inviting families to
participate in the study, 15 participants scheduled appointments to participate. One participant
relapsed prior to their scheduled date and one participant cancelled their appointment. Therefore,
a total of 13 participants completed the study. Also, matched controls were recruited from the
community following recruitment of survivors of ALL. They were age- (within six months) and
sex-matched with participants from the ALL survivor group. Controls were recruited from the
community through advertisement on social media.
Inclusion criteria for all participants included a minimum of low average (e.g., full scale
IQ two subtest of 80 or greater on the Wechsler Abbreviated Scale of Intelligence, 2nd Ed.)
intellectual functioning; no history of a moderate to severe head injury with loss of
consciousness, musculoskeletal injury, epilepsy, involuntary movement disorder, or motor
developmental delays, as these impairments would affect motor functioning; no history of a
DSM-5 neurodevelopmental disorder. Participants were not excluded based on sex, ethnicity, or
racial backgrounds. Given that diagnostic factors have been associated with motor performance
(Butler & Mulhern, 2005), participants were excluded for the ALL survivor group if they had a

	
  
MOTOR FUNCTIONING IN ALL

38

prior diagnosis of cancer other than ALL or had received radiation or a bone marrow transplant.
Also, the ALL survivors were only included if they were currently in maintenance treatment or
within two years post treatment cessation.
7.2 Participants
In total, 26 participants between the ages of 5 and 17 completed the study. Child
survivors of ALL ranged in age from 5 years, 9 months to 17 years, 7 months with a mean age of
11 years, 9 months. Healthy controls ranged in age from 5 years, 10 months to 17 years, 9
months with a mean age of 11 years, 8 months. There was no significant difference between the
ALL survivor and control groups in age (t(20) = 0.072, p = 0.94). Figure 1 illustrates the age in
years for each survivor-control pair. There was no significant difference between groups in
intellectual functioning as measured by the WASI two subtest IQ (FSIQ-2), t(28) = 0.90, p =
0.38 (ALL MFSIQ = 105.69; Control MFSIQ = 103.15). Tables 1 and 2 provide lists of all
demographic information for both the ALL survivor group and control group. Two participants
in the control group had a prior diagnosis of anxiety; no other mood or other psychological
disorders were reported in either the control or ALL survivor groups. All participants were righthanded.
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Figure 2. Age for each ALL survivor-control pair (ordered by age). This figure illustrates the age
in years for each age-, sex-matched pair.
Table 1
Percentage Frequency of Demographic Information for Children
Total Sample
ALL
Sex
Male
53.8
53.8
Female
46.2
46.2
Race
White
88.5
76.9
Biracial
11.5
23.1
Therapy History
Physical Therapy
30.8
53.8
Occupational
23.1
30.8
Therapy
Extracurricular Experience
Sports Experience
88.5
76.9
Musical Experience
26.9
15.4

Control
53
46.2
100
0
7.7
15.4
100
38.5
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Table 2
Percentage Frequency of Demographic Information for Parents
Total Sample
ALL
Relationship to Child
Mother
92.3
92.3
Father
7.7
7.7
Marital Status
Married
92.3
92.3
Divorced
7.7
7.7
Education (Mother/Father)
Some High School
0 / 3.8
0 / 7.7
High School
23.1 / 19.2
38.5 / 30.8
Diploma
Associates Degree
0 / 19.2
0 / 7.7
Bachelor’s Degree
53.8 / 26.9
46.2 / 23.1
Master’s Degree
19.2 / 23.1
15.4 / 30.8
Doctoral Degree
3.8 / 7.7
0/0
Income
Less than 24,999
15.4
30.8
25,000 to 49,999
15.4
15.4
50,000 to 74,999
15.4
0
Greater than 75,000
53.8
53.8

Control
92.3
7.7
92.3
7.7
0/0
7.7 / 7.7
0 / 30.8
61.5 / 30.8
23.1 / 15.4
7.7 / 15.4
0
15.4
30.8
53.8

Body mass index was calculated for each participant using reported weight and height.
Independent samples t-test results revealed a significant difference in BMI between the ALL
survivor group and control groups (t(28)=3.12, p=0.05). Table 3 lists descriptive statistics on
BMI for each group. Results suggest the ALL survivor group had significantly higher BMI
compared to age- and sex-matched controls.

Table 3
Body Mass Index Descriptive Statistics
Average
Total Sample
18.77
ALL Group
20.61
Control Group
16.94

Standard Deviation
3.48
3.68
2.08

Range
13.30-29.20
15.60-29.20
13.30-19.80
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Risk levels were reported from medical records for each participant. Treatment risk
classification for pediatric ALL is based on the patient’s age, white blood cell count, leukemiccell genotype, and response to induction therapy (Hunger et al., 2012; Pui, Campana, & Evans,
2001; Smith et al., 1996; Yeoh et al., 2002). This results in three possible risk categories, lowrisk, standard/intermediate-risk, and high-risk (Gaynon et al., 2000; Pui et al., 2001). Within the
13 ALL survivor group participants, 10 were classified as high-risk, 2 as standard risk, and 1 as
low risk. At the time of testing, six participants were in the maintenance stage of treatment and
seven had completed all stages of treatment (M Time since treatment cessation = 13.4 months; range = 12
months). Details were obtained regarding treatment history (Table 4). All of the ALL survivors
received intrathecal (IT) chemotherapy treatments that included methotrexate. None of the
participants received radiation therapy or a bone marrow transplant.

Table 4
Treatment Variables for ALL Survivors
Variable
Mean (SD)
Range
Age at Diagnosis (Years)
8.76 (5.01)
1-16
Time since Diagnosis (Months)
33.92 (14.36)
13-55
Vincristine (Doses)
34.84 (9.76)
22-51
2
Prednisone (Quantity in mg/m )
3310.92 (2737.19)
0-7280
Methotrexate (Doses)
19.92 (5.07)
13-33
2
Dexamethasone (Quantity in mg/m )
259.23 (163.89)
140-668
Note. Treatment cessation was only calculated for the 7 participants who were no longer in
maintenance therapy
Regarding school, a majority of the ALL survivors missed time from school due to
treatment (92.3%), which ranged from two days to an entire academic calendar year. One
participant repeated a grade due to treatment related absences. Several ALL survivors received
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academic assistance (69.2%), such as homebound schooling, tutoring, and reading specialists,
and only one control participant (7.7%) received academic assistance (i.e., speech therapy).
7.3 Procedures
A doctoral level graduate student completed all testing for this study. All participants in
the ALL survivor group participated in the study within a conference room located in the
Pediatric Oncology and Hematology department at Beaumont. Control participants participated
in the study in quiet, controlled environments in the community, including an office in the
Eastern Michigan University Psychology Clinic. Prior to completing study measures, parents
were provided with a written and verbal explanation of the purpose and procedures of the study.
Parents were then asked to sign a written informed consent, along with a receipt indicating they
received the gift card for participating. Additionally, children were presented with a verbal and
written assent form to participate in this study if they were between the ages of 13 and 17 years
old.
After parents signed the consent form, children were asked to begin testing, while parents
completed several parent-report questionnaires assessing motor, social, emotional, and
behavioral functioning. The study took approximately one and a half to two hours to complete.
The following measures were administered (see Tables 5 and 6). The Movement Assessment
Battery for Children, 2nd ed. (MABC-2; Henderson & Sugden, 1992) was administered to assess
gross and fine motor skills. Also, participants completed the Beery Visual-Motor Integration, 6th
ed. and the Visual Perception test, which assessed visuo-motor and visual-perceptual skills
respectively (Beery VMI; Beery & Beery, 2010). The Grooved Pegboard was also administered
to measure fine motor functioning (Lafayette Instrument, 2002). Additionally, the Test of
Handwriting Skills, Revised (THS-R; Milone, 2007) and the Wide Range Achievement Test, 4th
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ed. (WRAT-4; Wilkinson & Robertson, 2006) were completed to measure handwriting abilities
and academic skills (e.g., spelling and calculation) respectively. Cognitive functioning was
assessed with two scales from the Wechsler Abbreviated Scale of Intelligence, 2nd ed. (WASI-II;
Wechsler, 2011). The child participants were also asked to complete a self-report assessing
behavioral, emotional, and psychological functioning, along with a self-report measure of
physical fitness. In addition, treatment variables were obtained from each ALL survivors’
medical record by the nurse practitioner involved in this study, which included age of diagnosis,
protocol risk level, doses and quantity of treatment agents (e.g., vincristine, methotrexate), and
height and weight at start of treatment.
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Table 5
Performance Based Measures with Descriptions and Completion Times
Measure
Task Description
Movement Assessment
Battery for Children
(MABC-2)
Motor Adaptation Task

Grooved Pegboard
Beery VMI and Visual
Perception Test
Test of Handwriting
Skills, Revised
(THS-R)
Wechsler Abbreviated
Scale of Intelligence
(WASI-II)
Wide Range
Achievement Test
(WRAT-4)

Examiner Administered Measures
The MABC-2 measures three aspects of motor ability:
manual dexterity (e.g., pegboard), ball skills (e.g.,
throwing a ball), and static and dynamic balance (e.g.,
hopping).
Motor adaptation/learning are assessed with a
visuomotor computerized adaptation task. Requires that
participants move a joystick with their hand to hit a
target on the computer monitor.
A manipulative dexterity task that requires participants
place pegs in a pegboard as quickly as possible.
The VMI requires participants to copy increasingly
more challenging figures. The visual perception task
requires participants to identify visually similar forms.
Assesses handwriting abilities by having participants
write letters from memory, letters and words from
dictation, and copy letters.
The WASI-II is a brief measure of cognitive
functioning. The two subtest format was utilized, which
includes Vocabulary and Matrix Reasoning (i.e.,
abstract visual reasoning)
The WRAT-4 is a brief measure of academic
functioning. Two of the four subtests wasutilized,
including spelling and arithmetic (i.e., paper and pencil
calculation).

Time to
Complete
25 min

20 min

5 min
20 min
20 min
15 min

15 min
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Table 6
Self-Report Measures with Descriptions and Completion Times
Measure
Demographic/Health
history questionnaire
MABC Checklist
Developmental
coordination disorder
questionnaire
Physical Self
Description
Questionnaire-Short
Version
Behavior Assessment
System for Children
(BASC-3)

Task Description

Time to
Complete

Parent-Report Measures
A parent-report questionnaire assessing the child’s basic
demographic information, health and treatment history,
and musical/athletic experience.
A parent-report questionnaire assessing the child’s
motor functioning in multiple settings across a variety of
tasks.
A parent-report questionnaire assessing motor skills that
are indicative of Developmental Coordination Disorder.
Child-Report Measures
A self-report questionnaire assessing the child’s
perspective of their own physical well being.

Multi-Informant Report (Parent and Child)
A parent- and self-report questionnaire that assesses
various aspects of a child’s behavioral, emotional,
social, and adaptive functioning.

N/A
N/A
N/A

N/A

N/A

7.4 Performance Based Measures
Movement Assessment Battery for Children, 2nd ed. (MABC-2, Henderson &
Sugden, 1992). General motor functioning was assessed using the MABC-2, a standardized
assessment for children aged 3 to 16 years, 11 months (Henderson & Sugden, 1992; Henderson
et al., 2007). The MABC-2 assesses three aspects of motor ability across eight items: manual
dexterity (three items), ball skills (two items), and static and dynamic balance (three items). A
total impairment score was obtained by summing scores on all eight tasks (range 8 to 152). Total
scores were converted to standard scores and percentiles to compare the participants’
performance with same-aged children.
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The MABC-2 has been frequently used in clinical settings as well as in pediatric
oncology research (Green et al., 2013; Henderson, Sugden, & Barnett, 2007; Sabarre et al.,
2014). Adequate psychometric properties have been reported for the MABC-2, including internal
consistency (α = 0.76–0.90), test-retest reliability (ICC = 0.73–0.90), inter-rater reliability (k =
0.79–1.00), and concurrent validity with other motor assessments (r = 0.70–0.90) (Brown &
Lalor, 2009; Crock, Horvat, & McCarthy, 2001; Schulz et al., 2011). Also, the MABC-2 has
exhibited 74% sensitivity and 46% specificity for diagnosing developmental coordination
disorder (DCD; Wuang, Su, & Su, 2012). The MABC-2 is considered a reliable and sensitive
assessment for measuring a broad range of motor functioning.
Grooved Pegboard. Fine motor functioning was assessed using the Lafayette Grooved
Pegboard, a manipulative dexterity task (Lafayette Instrument, 2002). The Grooved Pegboard is
a standardized assessment with normative data for three age ranges: kiddie (5 years, 0 months to
8 years, 12 months), adolescent (9 years, 0 months to 14 years, 12 months), and adult (15 years,
0 months and above). Participants were required to place 25 pegs into a pegboard using only one
hand, starting with their dominant hand. The task was then repeated with the participants’ nondominant hand. Children aged 5 years, 0 months to 8 years, 12 months were required to only
complete the top two rows of the pegboard, or 10 pegs. Total testing time for both the dominant
and non-dominant hand performances were converted to z scores to compare the participants’
performance to same-aged children.
The Grooved Pegboard has displayed adequate test-retest reliability (ICC = 0.67–0.87) in
adults after intervals of 4 to 24 months (Levine, Miller, Becker, Selnes, & Cohen, 2004; Ruff &
Parker, 1993). Also, the Grooved Pegboard has been considered a sensitive instrument for a
variety of clinical populations, including stroke, autism, and lateral disturbances (Straus et al.,
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2006). In relation to academic performance, a moderate association has been observed between
the Grooved Pegboard and the arithmetic subtest on the Wide Range Achievement Test (WRAT)
(Solan, 1987). The Grooved Pegboard is a brief measure of manual dexterity with evident
clinical and empirical utility.
Beery-Buktenica Developmental Tests of Visual-Motor Integration and Visual
Perception, 6th ed. (Beery VMI, Beery & Beery, 2010). Visual-motor functioning was assessed
using the Beery VMI, a standardized assessment of visual-motor integration skills in children
aged 2 years, 0 months and older (Beery & Beery, 2010). Participants were asked to copy a
sequence (30 items) of geometric figures with increasing complexity. Additionally, participants
completed the supplemental Visual Perception test (Beery & Beery, 2010). This test attempts to
measure visual-perceptual abilities independent of fine motor skills, which are required of the
Visual Motor Integration task. On the Visual Perception test, participants were required to
identify identical matches of increasingly complex geometric forms (30 items). The total score
from both the Visual-Motor Integration and Visual Perception tests was converted to standard
scores and percentiles to compare participants’ performance with same-aged children.
Both the Visual-Motor Integration and the Visual Perception tests have adequate
psychometric properties. Moreover, both have reported acceptable internal consistency (VMI
α=0.82; Visual Perception α=0.81), good test-retest reliability (VMI ICC = 0.87; Visual
Perception ICC = 0.84), and excellent inter-rater reliability (VMI k = 0.94; Visual perception k =
0.98) (Beery & Beery, 2010). Also, the VMI has exhibited adequate concurrent validity with
Developmental Test of Visual Perception (DTVP-2) copying subtest (r = 0.75), while the VisualPerception test exhibited lower concurrent validity (r = 0.62) with the DTVP-2 position in space
subtest (Beery & Beery, 2010). Additionally, the Beery VMI has been used extensively in
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clinical and empirical work, as well as in pediatric oncology literature (Green et al., 2013).
Overall, the Beery VMI and Visual Perception tests appear to be appropriate assessment tools for
assessing visual-motor and visual-perceptual functioning.
Wide Range Achievement Test, 4th ed. (WRAT4, Wilkinson & Robertson, 2006).
Academic performance was assessed using the WRAT-4, a norm-referenced test of basic
academic skills (Wilkinson & Robertson, 2006). Normative data are available for individuals
aged 5 to 94 years old. The WRAT-4 consists of four academic subtests: word reading, sentence
comprehension, spelling, and math computation. For the purpose of this study, only subtests with
a motor component were administered, which included spelling and math computation. Scores
from each subtest were converted to standard scores (M = 100, SD = 15) to compare participants’
performance with same-aged peers.
The WRAT-4 has displayed adequate psychometric properties (Wilkinson & Robertson,
2006). Moreover, reported internal consistency are excellent for spelling (alpha=0.90–0.95) and
good to excellent for math computation (alpha = 0.87–0.94). Test-retest reliability for both
subtests are reportedly acceptable with a range from 0.83 to 0.94 for spelling and 0.79 to 0.95 for
math computation. Also, the intercorrelations between these two subtests range from 0.59 to
0.65. The spelling subtest of the WRAT-4 has displayed moderate to strong correlations (r =
0.64 to 0.89) with the spelling subtests from other academic measures, including the Wechsler
Individual Achievement Test, 2nd ed.., Woodcock-Johnson III Tests of Achievement, and the
Kaufman Test of Educational Achievement, 2nd ed... Similarly, the math computations subtest
has displayed moderate to strong correlations (r = 0.64 to 0.92) with comparable measures. Also,
reported correlations between the Wechsler Abbreviated Scale of Intelligence (WASI) Full Scale
IQ and WRAT-4 are weak for spelling (r = 0.46) and moderate for math computation (r = 0.60).
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Additionally, the WRAT-4 spelling and math computation subtests have displayed good
discriminant validity for learning disabilities and low or high cognitive abilities. With the
exception of low correlations with cognitive performance on the WASI, the spelling and math
computations subtests of the WRAT-4 appear to be valid and reliable measures of academic
skills in these domains.
Test of Handwriting Skills, Revised ed. (THS-R, Milone, 2007). Handwriting skills
were assessed using the THS-R, a standardized measure for quantifying manuscript or cursive
writing skills (Milone, 2007). Normative data are available for individuals aged 5 years, 0
months to 18 years, 11 months. Participants were asked to write letters from memory, write
letters and words from dictation, and copy letters, words, and sentences. Scaled scores for 10
subtests were combined. The total score was used to identify each participants’ overall standard
score based on age-based norms. The THS-R resulted in an overall standard score, as well as
evaluation of writing speed, letter reversal, and case substitutions. The THS-R has been
frequently utilized for progress monitoring when providing interventions, such as occupational
therapy. Psychometric properties are limited due to few studies utilizing the THS-R; however,
the THS-R has been considered a valid measure of handwriting skills (Wigal et al., 2011).
Wechsler Abbreviated Scale of Intelligence, 2nd ed. (WASI-II, Wechsler, 2011).
Participants were administered the WASI-II, which is a brief measure of cognitive functioning
(Wechsler, 2011). This measure is ideal for briefly assessing cognitive intelligence when timing
constraints prohibit the use of more extensive measures of intelligence. Moreover, the WASI-II
is appropriate for individuals aged 6 to 90 years old. The measure consists of four subtests
derived from the full Wechsler intelligence scales, including Vocabulary, Block Design, Matrix
Reasoning, and Similarities. A full-scale intelligence quotient can be derived from the sum of
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scores from all four subtests (FSIQ-4), as well as from only two subtests, Vocabulary and Matrix
Reasoning (FSIQ-2). For the purpose of this study, the FSIQ-2 was utilized to obtain a brief
assessment of cognitive abilities.
The WASI-II has displayed adequate to excellent psychometric properties (McCrimmon
& Smith, 2013). Moreover, excellent internal consistency has been reported for the FSIQ-4 (α =
0.96) and the FSIQ-2 (α = 0.93). High test-retest reliability has also been reported for both verbal
comprehension subtests, including Vocabulary and Similarities, (ICC = 0.98 to 0.99) and
perceptual reasoning subtests, including Block Design and Matrix reasoning (ICC = 0.94 to
0.95). Additionally, the WASI-II has exhibited acceptable (r = 0.71) to excellent (r = 0.92)
concurrent validity with other measures of intellectual functioning (i.e., Wechsler Intelligence
Scale for Children). Taken together, the WASI-II is a psychometrically sound tool for briefly
assessing cognitive functioning.
Visuomotor adaptation tasks. For the visuomotor adaptation task, each participant was
seated at a table and visual stimuli were presented on a laptop monitor. Participants were asked
to use their dominant hand to hold a joystick, which was utilized to collect digitized data of the
participants’ hand movements. Responses were collected in x/y coordinates at a sampling rate of
60 Hz. The adaptation task was written and was recorded in PRESENTATION. All time series
data were recorded and stored on a laboratory computer.
The visuomotor task required participants to move a cursor from a home position to
target positions displayed on a computer monitor. Throughout the task, a green circle was
displayed in the center of the screen and represented the home position. Eight yellow circular
targets (diameter 1 cm.) appeared randomly around the home position (distance from home
position to targets 10 cm) in one of eight locations (0o, 45o, 90o, 135o, 180o, 225o, 270o, 315o).
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Participants were required to keep the cursor in the home position motionless for 1 second before
a target appears. The target disappeared when the cursor entered the target circle.
The visuomotor task consisted of three phases. First participants completed three baseline
blocks with each block including eight trials for a total of 24 trials (three trials per angle). The
baseline blocks included normal visual feedback of the hand movements. Next, participants
completed 14 blocks of the exposure phase with each block including eight trials. During the
exposure phase the target was rotated 30o clockwise. Next participants complete one postexposure block with no rotation (i.e., same as baseline phase) that consists of eight trials (one
trial per angle). The post-exposure trial assessed for after-effects. There were also six blocks
including one trial with no adjusted rotation (one after every two exposure blocks; 6, 9, 12, 15,
18, and 21) in the exposure phase to monitor adaptation progress during the exposure blocks, or a
proxy of rate of learning. Across all trials, participants were asked to move the cursor as quickly
and straight as possible from the home position to the presented targets.
7.5 Self-Report Measures.
Demographic questionnaire. A 34-item self-report questionnaire (26-item for healthy
controls) was administered to participants’ parents. Basic demographic, medical, and family
information (age, education, diagnoses, head injuries, parent education level), along with musical
experience (i.e., years playing an instrument) and athletic experience (i.e., involvement in
organized sports) were collected from this questionnaire. For the ALL group only, information
about cancer diagnosis and treatment was obtained using this questionnaire.
Movement Assessment Battery for Children Checklist, 2nd ed. (MABC Checklist,
Henderson et al., 2007). The MABC checklist consists of a 43-item parent-report questionnaire
assessing a child’s motor abilities based on age-normed expectations (Henderson et al., 2007).
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Fifteen items are related to the child’s motor abilities in a static and/or predictable environment
(e.g., self-care skills, classroom skills, recreational skills), 15 items are related to motor abilities
in a dynamic and/or unpredictable environment (e.g., self-care skills, ball skills, recreational
skills), and 13 items are related to non-motor factors that may impact motor abilities (e.g.,
impulsivity, upset by failure). All questions are answered on a four-point scale, with the
exception of the final 13 questions being polar questions (i.e., yes or no). The total Motor
Competence score, which consists of the first 30 items, can be compared to same-aged peers.
Higher scores are indicative of poor motor abilities. The psychometric properties for the MABC
checklist are limited. Moreover, the MABC checklist has displayed excellent internal
consistency (α = 0.96) for the Motor Competence score (Schoemaker, Smits-Engelsman, &
Jongmans, 2003). Additionally, the MABC checklist has exhibited adequate specificity,
sensitivity, and predictive value for children with movement difficulties (Schoemaker et al.,
2003). In addition, the MABC checklist has been utilized to screen for parent-reported motor
difficulties in ALL survivors (Sabarre et al., 2014).
The Revised Developmental Coordination Disorder Questionnaire (DCDQ’07,
Wilson, Kaplan, Crawford, Campbell, & Dewey, 2000; Wilson, 2009). The DCDQ’07 is a
15-item parent-report for assessing motor abilities, such as movement control, fine motor
abilities, and general coordination, in children aged 5 to 15 years (Wilson et al., 2000; Wilson,
2009). The main purpose of the DCDQ’07 is to assess for coordination difficulties consistent
with a diagnosis of developmental coordination disorder (DCD) in children (Wilson et al., 2000).
Although the DCDQ’07 has been normed using data on children up to age 15, the original
developers have also used the DCDQ’07 with adolescent populations up to age 17 to identify
motor difficulties consistent with developmental coordination disorder (Crawford, Wilson, &
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Dewey2001). Each item is scored on a 5-point likert scale. Total scores were derived with a
maximum of 75 points. A total score equal to or less than 53 has been identified as being
indicative of motor difficulties consistent with developmental coordination disorder (Crawford et
al., 2001). The total raw score was used for data analysis in the present study.
The DCDQ’07 has displayed adequate psychometric properties. Moreover, the DCDQ’07
has exhibited good internal consistency (α = 0.94 to 0.97) and test-retest reliability (ICC = 0.94
to 0.97) (Wilson et al., 2009). The DCDQ’07 has displayed evident concurrent validity with the
MABC (r = -0.55) and the Test of Visual Motor Integration (TVMI; r = 0.42; Wilson et al.,
2009) as well as adequate discriminant validity with an overall specificity of 71% and sensitivity
of 85% (Wilson et al., 2009). Together, the DCDQ’07 appears to be a reliable and valid measure
for screening motor difficulties in children.
Physical Self-Description Questionnaire-Short Form (PSDQ-S; Marsh, Martin, &
Jackson, 2010): The PSDQ-S, based on the original Physical Self Description Questionnaire, is
a 40-item questionnaire assessing a child’s perception of the physical well being (Marsh et al.,
2010). Each item was scored on six-point Likert scale and resulted in a total score with high
scores indicating poor self-perception of physical well-being. Psychometric properties are
limited, though the PSDQ-S has displayed adequate test-retest reliability (ICC=0.77) and good
convergent and discriminant validity (Marsh et al., 2010). Additionally, one study found the
PDSQ full version did not correlate with parent-report (MABC checklist) and performance based
measures of a child’s motor skills, suggesting the PDSQ, or child perspective, offers a unique
understanding of a child’s motor abilities (Kennedy, Brown, & Chien, 2012).
Behavior Assessment System for Children, 3rd ed. (BASC-3, Reynolds & Kamphaus,
2015): The BASC-3 consists of self-report measures for parents and children to assess a child’s
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behaviors and emotions (Reynolds & Kamphaus, 2015). The parent-report comes in three forms
for various age levels including preschool (ages 2 to 5), child (ages 6 to 11), and adolescent (ages
12 to 21). Depending on the form used, the BASC-3 parent reports contain 139 to 175 items. The
parent-report yields four broad-band scores (e.g., internalizing symptoms, externalizing
symptoms, behavioral symptom index, and adaptive skills) along with 12 clinical and adaptive
subscales. Additionally, the two versions of the BASC-3 self-report were used, including child
(ages 8 to 11) and adolescent (ages 12 to 21). Similar to parent-report, the BASC-3 self-report
consists of four broad-band scores (e.g., school problems, internalizing problems,
inattention/hyperactivity, emotional symptoms index, personal adjustment) and 14 to 16 clinical
and adaptive subscales. Also, validity indices are derived for both the parent- and self-reports.
All items are based on a four-choice scale (e.g., never, sometimes, often, almost always).
Standard scores were derived for each subscale and composite based on same-aged peers. For the
purpose of this study, the following composites and subscales from the BASC parent-report were
used for data analysis: Internalizing Symptoms and Adaptive Skills composites and Anxiety,
Depression, Somatization, Adaptability, Social Skills, Leadership, Functional Communication,
and Activities of Daily Living subscales. Also, the following BASC self-report composites and
subscales were used for data analysis: Internalizing Symptoms and Personal Adjustment
composites and Atypicality, Locus of Control, Social Stress, Anxiety, Depression, Sense of
Inadequacy, Relationship with Parents, Interpersonal Relations, Self-Esteem, and Self-Reliance
subscales. The BASC self-report was completed by 22 of the 26 participants due to four
participants being under the age of 8.
The psychometric properties of the BASC-3 parent-report are strong. Specifically,
reliability coefficients are generally above 0.90 (α = 0.89 to 0.98) for the composites and above
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0.80 (α = 0.71 to 0.96) for the clinical and adaptive scales, suggesting adequate to excellent
internal consistency (Reynolds & Kamphaus, 2015). Test-retest reliability coefficients within a 7
to 70 day retest period generally fall above 0.80, suggesting adequate test-retest stability
(Wilkinson & Robertson, 2006). Also, inter-rater reliability is variable for the BASC-3 parentreport (k=0.47 to 0.87), though developers note these results are higher with reported inter-rater
reliability of other parent-report measures and are consistent with previous versions of the
BASC. Additionally, concurrent validity with other parent-report measures, such as the ASEBA
scales, Conners 3 Parent Form, and Autism Spectrum rating Scales, are reportedly moderate to
high. With regard to clinical groups, the BASC-3 parent form has displayed consistent symptom
profiles for ADHD, autism, and emotional/behavioral disturbance. Overall, the BASC-3 parentreport appears to be a reliable measure.
The psychometric properties for the BASC-3 self-report are also strong. Specifically,
internal consistency for the self-report is generally excellent (α = 0.86 to 0.97) for the composites
and adequate to good (α = 0.70 to 0.95) for the clinical and adaptive scales (Reynolds &
Kamphaus, 2015). Test-retest reliability within a 7 to 70 day retest period are generally adequate
with coefficients greater than 0.70. Additionally, the BASC-3 self-report has demonstrated
moderate to high concurrent validity with other youth self-report measures, such as the ASEBA
Youth Self-report, Conners 3 Self-Report, and the Delis Rating of Executive Functions. Similar
to the parent-report, the BASC-3 self-report appears to be a reliable and valid instrument for
assessing emotional, behavioral, and adaptive functioning in children.
7.6 Data Analysis
Data preparation. All data collected from neuropsychological testing and self-reports
were entered, coded, and double checked for errors by the principal investigator before analyses
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were performed. All of the original copies of data were password protected on the lab computer
or locked within a filing cabinet in the Cognitive Neuroscience lab at Eastern Michigan
University for future potential data checking. For analysis, all data were transferred to the
statistical software package SPSS (Statistical Package for the Social Sciences; IBM). Using
SPSS, data were further assessed for missing data and internal consistency.
For the visuomotor adaptation ask, data were collected and analyzed in MATLAB. A
dual-pass 8th-order Butterworth filter with a cutoff frequency of 10Hz was utilized to reduce
noise in the outcome data. Prior to data analysis, MATLAB scripts were used to mark the
starting point for each movement when the velocity exceeds 20% of the peak velocity.
Additionally, the experimenter manually adjusted markers when the algorithm failed to mark the
onset of the movement. The principal investigator and two undergraduate research assistants
trained by the principal investigator cleaned the visuomotor adaptation task data. All data were
standardized to the individual participant’s baseline. The visuomotor task yielded five dependent
variables used for analyses (See Table 7; Contreras-Vidal et al., 2005).

Table 7
Visuomotor Task Dependent Variables
Dependent Variable
Unit of
Description
Measurement
Directional Error (DE) Degrees
Directional deviation of the actual movement from the
ideal movement
Reaction Time (RT)
Milliseconds Time taken to move from the starting point to the peak
velocity time point
Movement Total
Millimeters
Total distance traveled by the joystick
Distance (DIST)
Movement Time (MT) Milliseconds Total time to move from the home position to the target
position
Root Mean Square
Millimeters
Average spatial deviation of the actual movement
Error (RMSE)
trajectory from the ideal movement trajectory from the
home position to the target position
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With regard to motor adaptation, two methods were utilized to assess the data. First,
motor adaptation was assessed by measuring change in performance across the exposure phase.
The Performance Change variable was calculated for each participant across all five variables
and consisted of the difference in performance between Block 23 (i.e., the last exposure phase
block) and Block 4 (i.e., the first exposure phase block). Next, the after effect was calculated for
each variable. This consisted of the difference in performance between Block 24 (i.e., the postexposure block) and Trial 4 (i.e., the last baseline block).
Statistical approach. The following statistical analyses were used for each specific aim:
1. To characterize the motor functioning of pediatric survivors of acute lymphoblastic
leukemia (ALL) across multiple domains of motor functioning. First, violations of
assumptions were assessed, including homogeneity, skew, and kurtosis. Next, descriptive
statistics were calculated, which included the mean, standard deviation, and range for
each dependent variable. Then, the relationship between time-based variables (i.e.,
current age and time since diagnosis) and all dependent variables was assessed using
correlational analyses (Kendall’s tau). Independent samples t-tests were used to assess
the group mean differences between stage of treatment (maintenance and completed
treatment) on all dependent variables. Finally, independent samples t-tests were
performed to assess group differences (ALL vs. control) across all dependent variables
assessing motor functioning (e.g., MABC, Beery VMI).
2. To investigate motor learning through a visuomotor adaptation task in survivors of ALL.
Line graphs were used to visually assess performance across each trial for both the ALL
and control groups for each of the adaptive dependent variables, including directional
error (DE), root mean square error (RMSE), movement time (MT), reaction time (RT),
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and total distance (DIST). Independent samples t-tests were used to assess the difference
in mean performance between the ALL survivor and control groups for Performance
Change (i.e., difference between first and last exposure trials) for each adaptation
dependent variable. Also, independent samples t-tests were used to assess the difference
in mean performance between the ALL survivor and control groups for After Effect (i.e.,
difference between the post exposure trial and the last baseline trial).
3. To evaluate the associations between motor functioning, across multiple domains (i.e.,
gross motor, fine motor, visual-motor), with each other and with both academic and
psychosocial functioning. To assess the relationship between fine motor and visualperceptual tasks with visual-motor integration, correlational analyses using Kendall’s tau
were conducted between fine motor tasks (i.e., Grooved Pegboard Dominant and Non
Dominant, MABC Manual Dexterity) and visual-perception with a visual-motor
integration task (Beery VMI). To assess the relationship between motor tasks and
academic measures, correlational analyses using Kendall’s tau were conducted between
all performance motor measures (e.g., Grooved Pegboard, VMI, MABC, THS) with the
WRAT Math and WRAT Spelling subtests. To assess the relationship between motor
tasks and psychosocial functioning, correlational analyses using Kendall’s tau were
conducted between all performance motor measures (e.g., Grooved Pegboard, VMI,
MABC, THS) with the BASC parent-report Internalizing and Adaptive Skills composites
and associated subscales as well as with the BASC self-report Internalizing and Personal
Adjustment composites and associated subscales.
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7.7 Assessment of Violation of Assumptions
For the present study, a prior power analysis of a two-sample t-test was used to determine
if the two independent populations’ (children with ALL versus healthy controls) means are
equivalent. Based on prior analyses a sample size of at least 28 was desired with an overall goal
of 40. The sample size in the present study is smaller than that was originally desired (26
participants total); therefore, results of testing may be underpowered and should be interpreted
with caution. Here, effect sizes were reported to illustrate the potential issues of power.
Levene’s test for homogeneity of variance revealed no significant differences in variance
between the ALL survivor group and the control group across most dependent variables (range
of p = .071 to .986). However, the homogeneity assumption was violated for the following
variables: DCDQ Total Score (p = .027), MABC Checklist Total Score (p = .000), PSDQ Body
Fat subscale (p = .023), BASC Self Social Stress subscale (p = .035), BASC Self Depression
subscale (p = .048), BASC Self Somatization subscale (p = .002), and BASC Self Interpersonal
Relations subscale (p = .012).
A significant negative skew was found for the ALL survivor group on PSDQ Total Score
(-2.01), PSDQ Global Physical subscale (-1.69), PSDQ Sports Competence subscale (-1.88),
PSDQ Coordination subscale (-1.38), and RMSE Performance Change (-1.88). A positive skew
was found on the BASC Parent Somatization (2.26) subscale and DE After Effect (1.24). Given
that the BASC Self has normative data starting at age 8, skew and kurtosis data were only
assessed for participants 8 years and older. For the ALL survivor group, a negative skew was
found on the BASC Self Relationship with Parents subscale (-1.43) and a positive skew was
found on the Atypicality (1.41) subscale. Leptokurtic kurtosis was found for the ALL survivor
group on PSDQ Total Score (4.97), PSDQ Global Physical subscale (2.39), PSDQ Sports
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Competence subscale (4.15), Parent BASC Somatization subscale (6.81), DE After Effect (2.81),
and RMSE Performance Change (4.27).
A significant negative skew was found for the control group on WRAT Math (-1.21),
Grooved Pegboard Non-Dominant (-1.453), PSDQ Global Physical subscale (-1.87), PSDQ
Body Fat subscale (-1.91), PSDQ Flexibility (-1.43), DIST After Effect (-1.83), and RT
Performance Change (-1.29). A positive skew was found on the MABC Checklist Total Score
(1.29), DE After Effect (3.09), DIST Performance Change (3.01), MT Performance Change
(1.16), RT After Effect (3.00), and RMSE Performance Change (1.45). On the BASC Self with
Control participants 8 years and older, there was a significant negative skew on the Relationship
with Parents subscale (-1.65) and a positive skew on Atypicality (1.46) and Depression (2.46).
Leptokurtic kurtosis was found for the control group on Visual Perception (2.62), Grooved
Pegboard Non-dominant (4.07), MABC Manual Dexterity (2.91), MABC Balance (2.91), PSDQ
Global Physical subscale (3.61), PSDQ Body Fat (3.62), BASC Self Depression subscale (6.91),
BASC Self Relationship with Parents (2.98), DE After Effect (10.47), DIST Performance
Change (10.19), DIST After Effect (5.44), MT Performance Change (3.72), RT Performance
Change (4.02), RT After Effect (9.94), and RMSE Performance Change (4.19).
Given the reported negative and positive skews and kurtosis as well as unequal variance
on select dependent variables. Of note, self-reports (e.g., PSDQ, BASC-Self) displayed the
greatest issues regarding normality and homogeneity. Also, significant concerns are indicated for
some variables from the Adaptation task, particularly for the control group. Reported violations
of assumptions may be a reflection of the small sample size and the distribution of ages as
previously displayed in Figure 2, rather than indication of problematic distributions in the
general populations.
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Chapter 8: Results

8.1 Aim 1: Motor Functioning
The study used normative data based on participants’ age to calculate standard, scale, or
T-scores for each dependent variable. Descriptive statistics were performed across all measures
for both the ALL survivor group and control group, including means, standard deviations, and
ranges. Results of descriptive statistics are listed in Tables 8, 9, 10, and 11.

Table 8
Descriptive Statistics of Standard Scores for Performance Based Measures
Dependent Variable
ALL
Control
M/(SD)
Range
M/(SD)
Range
WRAT Spelling
105.38(13.31)
80–128
110.23(15.63)
91–138
WRAT Math
101.54(15.55)
72–125
104.15(12.41)
75–117
VMI
85.23(14.57)
57–106
92.38(11.72)
75–112
Visual Perception
88.46(13.51)
58–109
100.31(9.22)
77–112
Pegboard Dominant
44.08(8.85)
23.9–54.4
57.32(7.50)
39.5–8.6
Pegboard Non47.05(9.96)
25.2–57.1
54.72(7.28)
35.2–64.9
dominant
MABC Manual
5.77(1.54)
2–8
8.77(1.36)
6–12
Dexterity
MABC Aiming &
9.15(2.64)
5–15
13.00(2.45)
9–17
Catching
MABC Balance
6.31(2.46)
1–10
10.08(1.61)
7–14
MABC Total
5.69(2.25)
1–10
10.69(1.25)
8–12
THS
100.46(11.60)
81–117
105.31(11.54)
90–126
Note. WRAT Spelling, WRAT Math, VMI, Visual Perception, and THS are standard scores
(M=100). Grooved Pegboard dominant and non-dominant are T-scores (M=50). MABC variables
are scaled scores (M=10).
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Table 9
Descriptive Statics for Parent-Report Measures
Dependent Variable
ALL
Control
M/(SD)
Range
M/(SD)
Range
DCDQ Total
59.31(15.33)
30–75
63.62(7.77)
51–75
MABC Checklist Total 11.69(12.60)
0–35
2.93(3.95)
0–11
BASC Parent
Internalizing Problems
47.46(6.74)
39–62
46.77(6.94)
37–60
Composite
Anxiety
43.92(7.87)
31–59
51.23(12.00)
36–79
Depression
44.54(4.05)
38–52
45.31(6.33)
37–55
Somatization
54.92(11.57)
42–89
45.31(3.28)
40–51
Adaptive Skills
58.08(8.29)
45–69
60.31(8.92)
48–75
Composite
Adaptability
57.62(7.68)
44–71
60.46(9.16)
40–72
Social Skills
58.46(7.23)
49–70
57.85(6.18)
46–66
Leadership
58.00(7.84)
45–71
56.50(9.60)
43–71
Activities of Daily
53.92(10.40)
35–69
59.08(11.02)
46–77
Living
Functional
55.85(8.27)
40–67
59.92(7.57)
45–71
Communication
Note. DCDQ Total and MABC Checklist are raw scores totals. All BASC variables are T-scores
(M=50). Levene’s test indicated unequal variances for DCDQ Total (p = .027) and MABC
Checklist Total (p < .001).
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Table 10
Descriptive Statistics for the Physical Self Description Questionnaire (PSDQ)
Dependent Variable
ALL
Control
M/(SD)
Range
M/(SD)
Range
Total Average
4.49(0.78)
2.3–5.3
5.15(0.59)
4.1–5.9
Esteem
5.11(0.74)
3.6–6.0
5.31(0.66)
4.2–6.0
Appearance
4.05(1.25)
1.0–6.0
4.91(0.78)
3.7–5.7
Global Physical
5.01(1.32)
1.7–6.0
5.30(0.98)
2.7–6.0
Body Fat
4.90(1.08)
3.0–6.0
5.60(0.60)
4.0–6.0
Health
3.40(1.25)
1.6–5.6
5.08(1.03)
3.2–6.0
Sport Competence
4.75(1.38)
1.0–6.0
5.12(0.65)
4.3–6.0
Strength
4.72(1.23)
2.0–6.0
4.90(0.73)
3.7–6.0
Coordination
4.89(1.13)
2.4–6.0
5.14(1.00)
3.0–6.0
Physical Activity
4.60(1.43)
1.3–6.0
4.96(0.94)
3.0–6.0
Flexibility
3.84(1.67)
1.3–6.0
5.02(1.03)
2.7–6.0
Endurance
4.10(1.25)
1.0–5.7
5.02(0.88)
3.3–6.0
Note. The PSDQ Total Average is the average across 40 items and the subscales are the average
across the associated items with higher scores indicating more positive perceptions. Levene’s test
indicated unequal variances for PSDQ Body Fat (p = .023).
Table 11
Descriptive	
  Statistics	
  for	
  Behavior	
  Assessment	
  System	
  for	
  Children	
  (BASC)	
  Self	
  -‐Report	
  
Dependent Variable
ALL
Control
M/(SD)
Range
M/(SD)
Range
Internalizing
44.00(7.96)
36–57
39.82(4.53)
33–49
Composite
Atypicality
45.00(7.13)
39–61
40.27(4.08)
36–50
Locus of Control
43.82(8.15)
37–59
43.45(8.58)
35–62
Social Stress
45.36(7.93)
36–61
40.91(5.36)
34–50
Anxiety
45.55(6.09)
37–55
38.91(5.82)
32–49
Depression
43.09(5.01)
37–51
40.73(5.14)
37–55
Sense of Inadequacy
42.64(7.66)
32–55
41.00(4.00)
33–47
Personal Adjustment
58.45(4.63)
52–66
60.00(5.31)
50–67
Index
Relations with Parents
59.45(4.41)
49–65
58.18(7.26)
41–65
Interpersonal Relations 54.73(6.34)
42–62
58.91(3.18)
52–63
Self-Esteem
54.00(4.20)
48–60
56.09(2.95)
52–60
Self-Reliance
59.64(4.46)
53–65
58.36(7.49)
47–69
Note. All BASC variables are T-scores (M = 50). All composites and subscales include a sample
of 22 participants due to 4 participants being under the age of 8. Levene’s test indicated unequal
variances for Social Stress (p = .035), Depression (p = .048), Somatization (p = .002), and
Interpersonal Relations (p = .012).

	
  
MOTOR FUNCTIONING IN ALL

64

Time based variables and sex. Given the age range of the sample (5 to 17 years old),
correlational analyses using Kendall’s tau were used to assess the relationship between age with
all dependent variables. Correlational results revealed older age related to lower performance on
the Beery VMI (τ (26) = -0.419, p = .003), better performance on the THS (τ (26) = 0.287, p=
.042), worse perceived flexibility on the PSDQ (τ (26) = -0.308, p = .036), less parent reported
motor concerns based on the MABC Checklist Total (τ (26) = -0.306, p = .036), and less selfreported self-reliance skills based on the BASC self-report (τ (22) = -0.5391, p = .013). Also,
correlational analyses using Kendall’s tau were used to assess the relationship between age at
diagnosis with all dependent variables. Correlational results revealed older age at diagnosis
related to more self-reported internalizing symptoms (τ (11) = 0.561, p = .018), worse locus of
control (τ (11) = 0.505, p = .037), more anxiety (τ (11) = 0.587, p = .012), and more depression
(τ (11) = 0.547, p = .022), and less self-reliance skills (τ (11)= -0.558, p=0.021) on the BASC.
Also, results revealed older age at diagnosis was associated with lower performance on the
Grooved Pegboard Dominant (τ (13) = -0.442, p = .037) and Grooved Pegboard Non-dominant
(τ (13) = -0.477, p = .024). The time lapsed between age at diagnosis and age at the evaluation
was calculated. Correlational results revealed no significant association between time since
diagnosis with all dependent variables.
Additionally, given that participants in the ALL survivor group differed in their stage of
treatment, differences were examined using independent samples t-tests with the groups
dichotomized (maintenance chemotherapy vs. completed medical treatment). Results revealed
participants from the ALL survivor group still on maintenance chemotherapy at the time of
testing reported significantly greater concerns of depression (M = 46.83; SD = 3.37) than those
who had completed medical treatment (M = 38.60; SD = 1.52), t(11) = 5.366, p = .001, d = 3.15.
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Also, participants receiving maintenance chemotherapy reported significantly greater anxiety
symptoms (M = 50.17; SD = 3.71) than those who had medical treatment (M = 40.00; SD =
2.24), t(11) = 5.344, p < .001, d = 3.32. No other significant differences were found between
treatment groups across all other variables.
In addition, sex was also considered, as it could account for variance in the results.
Independent samples t-tests were performed to assess the relationship between sex and all
dependent variables. Results of t-tests revealed no significant difference in performance between
males and females across performance based motor measures, parent-reports, and self-reports.
In summary, interpretation should be made cautiously for several variables given the
above-mentioned relationships between age at evaluation, age at diagnosis, and stage of
treatment with several dependent variables. Of note, although age effects were noted for several
variables, the study groups were matched based on age; therefore, the effect of age should be
minimized when comparing the two groups.
Motor functioning analyses: It was hypothesized that ALL survivors would display
lower performance across all performance, parent-report, and self-report measures assessing
motor functioning. Independent sample t-tests were used to assess mean differences between the
groups. Due to the small samples size, effect sizes were computed for each analysis to assess the
magnitude of the mean differences. On performance measures (see Table 12), the ALL Survivor
group performed lower compared to the Control group with large effect sizes on Visual
Perception (t(26) = 2.611, p < .015, d = 1.02), Grooved Pegboard Dominant hand (t(26) = 4.114,
p < .001, d = 1.61), Grooved Pegboard Non-Dominant hand (t(26) = 2.238, p = .035, d = 0.88),
MABC Manual Dexterity (t(26) = 5.267, p < .000, d = 2.06), MABC Aiming & Catching (t(26)
= 3.850, p = 0.001, d = 1.51), MABC Balance (t(26) = 4.623, p < .001, d = 1.81), MABC Total
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(t(26) = 7.002, p < .000, d = 2.75). No significant differences were found between the ALL
Survivor group and the Control group for VMI and THS.

Table 12
Independent Samples t-Test Results for Performance Measures
Dependent Variable
t
p
d

ALL M/(SD)

Control
M/(SD)
92.38(11.72)
100.31(9.22)
57.32(7.50)
54.72(7.28)
8.77(1.36)
13.00(2.45)

VMI
1.379
0.181
0.54
85.23(14.57)
Visual Perception
2.611
0.015*
1.02
88.46(13.51)
Pegboard Dominant
4.114
0.000*
1.61
44.08(8.85)
Pegboard Non-dominant
2.238
0.035*
0.88
47.05(9.96)
MABC Manual Dexterity
5.267
0.000*
2.06
5.77(1.54)
MABC Aiming &
3.850
0.001*
1.51
9.15(2.64)
Catching
MABC Balance
4.623
0.000*
1.81
6.31(2.46)
10.08(1.61)
MABC Total
7.002
0.000*
2.75
5.69(2.25)
10.69(1.25)
THS
1.068
0.296
0.42
100.46(11.60) 105.31(11.54)
Note. * Significance level p < .05. WRAT Spelling, WRAT Math, VMI, Visual Perception, and
THS are standard scores (M=100). Grooved Pegboard dominant and non-dominant are T-scores
(M=50). MABC variables are scaled scores (M=10).
On parent-report measures assessing motor functioning (see Table 13), parents from the
ALL survivor group reported significantly more concerns regarding their child’s motor skills
compared to the parents from the control group as reported by the MABC Checklist Total score
with a large effect size (t(26) = 2.395, p = .031, d = 0.94). No significant difference was
observed between the ALL survivor group and the control group on the DCDQ Total. Results for
both parent-report measures accounted for adjusted degrees of freedom for both t-tests due to
unequal variances indicated by Levene’s test. On self-report measures assessing motor
functioning (see Table 14), results of independent samples t-tests revealed the ALL survivor
group reported significantly lower total physical self-perception (t(26) = 2.430, p = .023, d =
0.95), appearance (t(26) = 2.084, p = .048, d = 0.83), health (t(26) = 3.723, p = .001, d = 1.47),
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flexibility (t(26) = 2.168, p = .040, d = 0.85), and endurance (t(26) = 2.183, p = .039, d = 0.85),
as indicated by the PSDQ Health subscale, compared to the control group with a large effect size.
No significant differences were found for the other PSDQ subscales. Results for the PSDQ Body
Fat subscale accounted for adjusted degrees of freedom due to unequal variances indicated by
Levene’s test.

Table 13
Independent Samples t-Test Results for Parent Report Measures
Dependent Variable
t
p
d

ALL M/(SD)

Control
M/(SD)
DCDQ Total
0.904
0.375
0.23
59.31(15.33) 63.62(7.77)
MABC Checklist Total
2.395
0.031*
0.94
11.69(12.60) 2.93(3.95)
Note. * Significance level p < .05. DCDQ Total and MABC Checklist are raw scores totals. On
the MABC Checklist, higher scores indicated more concerns regarding motor functioning. On
the DCDQ, lower concerns indicate more concerns regarding motor skills. Levene’s test
indicated unequal variances for DCDQ Total (p=0.027) and MABC Checklist Total (p < .001).

Table 14
Independent Samples t-Test Results for PSDQ
Dependent Variable
t
p

d

ALL M/(SD)

Control
M/(SD)
Total Average
2.430
0.023*
0.95
4.49(0.78)
5.15(0.59)
Esteem
0.728
0.474
0.29
5.11(0.74)
5.31(0.66)
Appearance
2.084
0.048*
0.83
4.05(1.25)
4.91(0.78)
Global Physical
0.640
0.528
0.25
5.01(1.32)
5.30(0.98)
Body Fat
2.038
0.056
0.80
4.90(1.08)
5.60(0.60)
Health
3.723
0.001*
1.47
3.40(1.25)
5.08(1.03)
Sport Competence
0.873
0.391
0.34
4.75(1.38)
5.12(0.65)
Strength
0.465
0.646
0.18
4.72(1.23)
4.90(0.73)
Coordination
0.586
0.563
0.23
4.89(1.13)
5.14(1.00)
Physical Activity
0.761
0.454
0.30
4.60(1.43)
4.96(0.94)
Flexibility
2.168
0.040*
0.85
3.84(1.67)
5.02(1.03)
Endurance
2.183
0.039*
0.85
4.10(1.25)
5.02(0.88)
Note. * Significance level p < .05. The PSDQ Total Average is the average across 40 items and
the subscales are the average across the associated items with higher scores indicating more
positive perceptions. Levene’s test indicated unequal variances for PSDQ Body Fat (p = .023).
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8.2 Aim 2: Motor Adaptation
It was hypothesized that participants in the ALL survivor group would perform
significantly worse on measures of motor adaptation compared to the control group. First,
analysis of performance over trials between the two groups was visually assessed using line
graphs for the five adaptation variables, including DE, DIST, MT, RT, and RMSE (See Figures
3, 4, 5, 6, and 7).
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Figure 3. Directional error (DE) across trials. This figure illustrates the average directional error
in degrees for each group (ALL and control) for each trial across the task. The baseline phase
includes Blocks 1 through 3, the exposure phase includes Blocks 4 through 24, the post exposure
phase includes Block 24. Blocks 6, 9, 12, 15, 18, and 21 include one catch trial.
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Figure 4. Movement Total Distance (DIST) across trials. This figure illustrates the average
movement total distance in millimeters for each group (ALL and control) for each trial across the
task. The baseline phase includes Blocks 1 through 3, the exposure phase includes Blocks 4
through 24, the post exposure phase includes Block 24. Blocks 6, 9, 12, 15, 18, and 21 include
one catch trial.
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Figure 5. Movement Time (MT) across trials. This figure illustrates the average movement time
in milliseconds for each group (ALL and control) for each trial across the task. The baseline
phase includes Blocks 1 through 3, the exposure phase includes Blocks 4 through 24, the post
exposure phase includes Block 24. Blocks 6, 9, 12, 15, 18, and 21 include one catch trial.
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Figure 6. Reaction Time (RT) across all trials. This figure illustrates the average reaction time in
milliseconds for each group (ALL and control) for each trial across the task. The baseline phase
includes Blocks 1 through 3, the exposure phase includes Blocks 4 through 24, the post exposure
phase includes Block 24. Blocks 6, 9, 12, 15, 18, and 21 include one catch trial.
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Figure 7. Root Mean Square Error (RMSE) across all trials. This figure illustrates the average
root mean square error in milliseconds for each group (ALL and control) for each trial across the
task. The baseline phase includes Blocks 1 through 3, the exposure phase includes Blocks 4
through 24, the post exposure phase includes Block 24. Blocks 6, 9, 12, 15, 18, and 21 include
one catch trial.
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Independent samples t-tests were used to assess the difference in mean performance for
Performance Change across the five target variables between the ALL survivor group and the
control group. Performance Change captured the difference in performance between Trial 23
(i.e., last exposure trial) and Trial 4 (i.e., first exposure trial). Effect sizes were calculated for
each test. Results of independent samples t-tests revealed no significant difference between the
groups across the five target variables for Performance Change (see Table 15). In addition,
independent samples t-tests were used to assess the difference in mean performance for the After
Effect for the five target variables between the ALL survivor group and the control group. After
Effect captured the difference in performance between Trial 24 (i.e., post exposure trial) and
Trial 3 (i.e., last baseline trial). Results of independent samples t-tests revealed no significant
difference between the groups across the five target variables for After Effect (See Table 16).
Table 15
Independent Samples t-Test Results for Performance Change
Adaptation
t
p
d
ALL M(SD)
Variable
DE
-1.640
0.114
0.64
-17.98(13.44)
DIST
-1.749
0.092
0.69
-73.01(77.70)
MT
-1.550
0.099
0.61
-558.73(573.27)
RT
-0.749
0.461
0.29
-73.50(297.77)
RMSE
-0.883
0.386
0.35
-11.78(7.01)

Control M(SD)
-9.91(11.57)
-5.91(114.45)
-274.61(329.75)
22.27(351.93)
-9.20(7.89)

Table 16
Independent Samples t-Test Results for After Effect
Adaptation
t
p
d
Variable
DE
0.242
0.811
0.09
DIST
-0.657
0.518
0.26
MT
-0.157
0.876
0.06
RT
-0.772
0.448
0.30
RMSE
-1.336
0.194
0.52

ALL M(SD)

Control M(SD)

-13.02(11.63)
3.75(75.89)
265.26(710.70)
-94.69(373.72)
6.45(8.79)

-11.84(13.24)
20.56(52.60)
299.28(320.47)
17.21(365.58)
10.36(5.83)

	
  
MOTOR FUNCTIONING IN ALL

72

It was also hypothesized that motor adaptation would significantly correlate with fine
motor and visual-motor performance. The Bonferroni adjusted p-value for these correlational
analyses was .002 (.05/25), which accounts for the multiple tests performed. Results from
correlational analyses using Kendall’s tau revealed no significant correlations between the motor
adaptation task with fine motor skills, including grooved pegboard dominant and non-dominant
hands, MABC manual dexterity, visual-motor functioning, as measured by the Beery VMI, and
visual-spatial skills, as measured by the Beery Visual Spatial task for both the ALL survivor
group (see Table 17) and control group (see Table 18). Of note, the correlation between
Movement Time and Visual Spatial skills approached significance for the ALL survivor group
(τ(13) = -0.44, p = .037), though did not meet the significance threshold according to the
Bonferroni correction.

Table 17
ALL Survivor Group Kendall’s Tau Correlations Between Fine Motor, Visual-Motor, and Motor
Adaptation
DE
DIST
MT
RT
RMSE
PD
0.07
0.12
-0.22
-0.17
0.04
PN
0.03
0.03
0.10
-0.05
0.21
MABC MD
0.30
0.13
0.01
0.04
-0.25
VMI
-0.22
-0.07
-0.32
-0.22
0.04
VP
-0.39
-0.26
-0.44*
0.03
-0.03
Note. * Trending toward significance p < .05. Correlations include 13 participants. PD: Grooved
Pegboard Dominant, PN: Grooved Pegboard Non-dominant, MD: MABC Manual Dexterity,
VM: Visual-motor Integration, VP: Visual Perception, DE: Directional Error, DIST: Movement
Total Distance, MT: Movement Time, RT: Reaction Time, RMSE: Root Mean Square Error.
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Table 18
Control Group Kendall’s Tau Correlations Between Fine Motor, Visual-Motor, and Motor
Adaptation
DE
DIST
MT
RT
RMSE
PD
-0.16
0.10
0.10
0.21
0.13
PN
0.04
0.30
0.35
-0.07
0.07
MABC MD
0.17
0.23
0.20
-0.05
0.02
VMI
-0.17
-0.22
0.14
-0.04
-0.19
VP
-0.34
-0.13
-0.18
-0.13
0.08
Note. Correlations include 13 participants. PD: Grooved Pegboard Dominant, PN: Grooved
Pegboard Non-dominant, MD: MABC Manual Dexterity, VM: Visual-motor Integration, VP:
Visual Perception, DE: Directional Error, DIST: Movement Total Distance, MT: Movement
Time, RT: Reaction Time, RMSE: Root Mean Square Error.
8.3 Aim 3: Relationship Between Motor and Academic/Psychosocial Functioning
Correlational analyses using Kendall’s tau were conducted to assess the three
components of the third hypothesis. Due to repeated analyses, a Bonferroni correction was
applied when evaluating all correlation analyses to reduce the likelihood of Type I errors. All
correlations with a p-value less than or equal to .05 were also reported to highlight trends toward
significance and avoid Type II errors.
Visual-Motor. It was hypothesized that fine motor and visual spatial abilities would
significantly correlate with visual-motor performance. The Bonferroni adjusted p-value for these
correlational analyses was .0125 (.05/4), which accounts for the multiple tests performed on the
visual-motor variable. For the ALL survivor group (see Table 19), results from correlational
analyses using Kendall’s tau revealed a positive correlation between performance on the
Grooved Pegboard Dominant and Beery VMI (τ(13) = 0.73, p = .001), suggesting dominant hand
fine motor skills are strongly related to visual-motor skills in the ALL Survivor group. Also,
there was a positive correlation between Grooved Pegboard Non-dominant and Beery VMI that
approached significance within the ALL survivor group (τ(13) = 0.43, p = .044). No significant
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correlations were found between the Beery VMI and MABC Manual Dexterity, as well as with
Visual Perception for the ALL survivor group. No significant correlations were found between
the VMI and fine motor tasks (Grooved Pegboard and MABC Manual Dexterity) as well as with
Visual Perception for the control group (see Table 20).

Table 19
ALL Survivor Group Kendall’s Tau Correlations Between Fine Motor Tasks and VMI
Visual-Motor Integration
Grooved Pegboard Dominant
0.73**
Grooved Pegboard Non-dominant
0.43*
MABC Manual Dexterity
0.26
Visual Perception
0.38
Note. ** Significance level p < .0125. * Trending toward significance p < .05. Correlations
include 13 participants.
Table 20
Control Group Kendall’s Tau Correlations Between Fine Motor Tasks and VMI
Visual-Motor Integration
Grooved Pegboard Dominant
-0.21
Grooved Pegboard Non-dominant
0.03
MABC Manual Dexterity
0.14
Visual Perception
0.38
Note. Correlations include 13 participants.

Academic. It was hypothesized that performance on motor measures, including Grooved
Pegboard, VMI, Visual Perception, MABC Manual Dexterity, MABC Aiming & Catching,
MABC Balance, MABC Total, and THS, would significantly correlate with performance on the
WRAT Math and Spelling subtests. The Bonferroni adjusted p-value for these correlational
analyses was .0028 (.05/18), which accounts for the multiple paired correlations performed. For
both the ALL survivor group and the control group, no significant Kendal tau correlations were

	
  
MOTOR FUNCTIONING IN ALL

75

found between performance motor measures and academic measures, including math and
spelling (see Table 21 and 22).

Table 21
ALL Survivor Group Kendall’s Tau Correlations Between Motor and Academic Tasks
WRAT Math
WRAT Spelling
Grooved Pegboard Dominant
-0.03
0.01
Grooved Pegboard Non-dominant
-0.17
-0.05
Visual-Motor Integration
0.03
0.17
Visual Perception
-0.07
0.32
MABC Manual Dexterity
0.12
-0.04
MABC Aiming & Catching
0.09
0.16
MABC Balance
-0.23
-0.07
MABC Total Score
-0.12
0.00
Test of Handwriting Skills
0.30
0.32
Note. Correlations include 13 participants.
Table 22
Control Group Kendall’s Tau Correlations Between Motor and Academic Tasks
WRAT Math
WRAT Spelling
Grooved Pegboard Dominant
-0.08
-0.03
Grooved Pegboard Non-dominant
0.14
0.14
Visual-Motor Integration
0.30
0.09
Visual Perception
0.26
0.00
MABC Manual Dexterity
0.33
0.08
MABC Aiming & Catching
-0.19
0.14
MABC Balance
-0.07
0.19
MABC Total Score
0.09
0.25
Test of Handwriting Skills
-0.20
0.25
Note. Correlations include 13 participants.
Psychosocial. It was hypothesized that performance-based motor measures would be
significantly correlated with measures assessing psychosocial functioning, as reported by parents
and participants. The Bonferroni adjusted p-value for these correlational analyses was .0006
(.05/90), which accounts for the multiple tests performed. Correlational analyses using Kendall’s
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tau revealed two correlations between motor measures and the BASC parent-report
scales/composites that approached significance, though did not reach significance based on the
adjusted Bonferroni p-value (see Table 23). First, better ball skills as measured by the MABC
Aiming and Catching composite was associated with less parent-reported leadership skills on the
BASC (τ(13) = -0.47, p = .042). Additionally, better handwriting performance on the THS Total
was associated with less parent-reported concerns of somatization on the BASC (τ(13) = -0.48, p
= .026).

Table 23
ALL Survivor Group Kendall’s Tau Correlations Between Motor Tasks and Parent-Report
Psychosocial Composites and Subscales
PD

INT
0.08

ANX
0.01

DEP
-0.11

SOM
0.09

ASK
-0.13

ADP
-0.15

SSK
-0.01

LEA
-0.14

FCO
-0.23

ADL
-0.13

PN

-0.04

-0.21

-0.20

0.00

-0.22

-0.21

-0.30

-0.34

-0.29

-0.14

VM

0.03

0.04

-0.08

-0.01

-0.18

-0.04

-0.12

-0.22

-0.28

-0.26

VP

0.01

0.18

0.12

-0.16

-0.20

0.27

-0.25

-0.19

-0.05

-0.22

MD

0.03

-0.16

-0.20

0.19

-0.03

-0.13

-0.09

0.16

-0.33

0.12

AC

0.01

-0.05

-0.01

-0.06

-0.36

-0.30

-0.18

-0.46*

-0.41

-0.18

BA

0.16

-0.03

-0.04

0.17

-0.35

-0.07

-0.33

-0.23

-0.42

-0.20

TO

0.11

-0.07

-0.06

0.11

-0.35

-0.08

-0.30

-0.23

-0.42

-0.18

TH

-0.38

-0.37

0.01

-0.48*

-0.04

0.11

-0.19

0.05

-0.19

0.22

Note. * Trending toward significance p < .05. Correlations include 13 participants. INT:
Internalizing Symptoms Index, ANX: Anxiety, DEP: Depression, SOM: Somatization, ASK:
Adaptive Skills Composite, ADP: Adaptability, SSK: Social Skills, LEA: Leadership, FCO:
Functional Communication; ADL: Activities of Daily Living, PD: Grooved Pegboard Dominant,
PN: Grooved Pegboard Non-dominant, VM: Visual-motor Integration, VP: Visual Perception,
MD: MABC Manual Dexterity, AC: MABC Aiming & Catching, BA: MABC Balance, TO:
MABC Total Score, TH: Test of Handwriting Skills.
For the control group, correlational analyses using Kendall’s tau revealed correlations
approaching significance, though no correlations met significance based on the adjusted
Bonferroni p-value (see Table 24). First, lower fine motor performance on the Grooved Pegboard
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Non-dominant was associated with higher parent-reported concerns of depression, (τ(13) = -0.43,
p = .042) and worse adaptive skills (rτ(13) = 0.50, p = .020), specifically adaptability (τ(13) =
0.55, p = .011). Additionally, a lower visual-motor performance on the Beery VMI was
associated with worse social skills (τ(13) = 0.48, p = .023). Lower overall motor performance on
the MABC was associated with more concerns of Internalizing symptoms (τ(13) = -0.45, p =
.048), including anxiety τ(13) = -0.57, p = .012), and depression τ(13) = -0.47, p = .040). And
finally, lower ball skills (τ(13) = -0.44, p = .046) and balance (τ(13) = -0.53, p = .020) were
associated with more concerns of anxiety.

Table 24
Control Group Kendall’s Tau Correlations Between Motor Tasks and Parent-Report
Psychosocial Composites and Subscales
PD

INT
-0.16

ANX
-0.27

DEP
-0.16

SOM
0.20

ASK
0.17

ADP
0.28

SSK
0.00

LEA
0.11

FCO
0.12

ADL
-0.05

PN

-0.38

-0.28

-0.43*

-0.08

0.50*

0.55*

0.33

0.31

0.40

0.28

VM

0.20

0.33

0.12

-0.19

0.18

0.05

0.48*

0.00

0.03

0.17

VP

0.26

0.35

0.12

-0.12

0.17

0.08

0.08

0.05

0.09

0.21

MD

-0.06

0.02

-0.22

-0.13

0.23

0.17

0.14

0.19

0.19

0.23

AC

-0.33

-0.44*

-0.16

0.03

0.07

0.12

-0.24

0.13

0.17

0.11

BA

-0.42

-0.53*

-0.37

-0.06

-0.04

0.02

-0.31

0.17

-0.03

-0.04

TO

-0.45*

-0.57*

-0.47*

-0.22

0.09

0.15

-0.30

0.20

0.22

0.25

TH

-0.22

-0.23

-0.23

-0.24

0.08

0.11

-0.04

0.25

0.00

0.25

Note. * Trending toward significance p <0.05. Correlations include 13 participants. INT:
Internalizing Symptoms Index, ANX: Anxiety, DEP: Depression, SOM: Somatization, ASK:
Adaptive Skills Composite, ADP: Adaptability, SSK: Social Skills, LEA: Leadership, FCO:
Functional Communication; ADL: Activities of Daily Living, PD: Grooved Pegboard Dominant,
PN: Grooved Pegboard Non-dominant, VM: Visual-motor Integration, VP: Visual Perception,
MD: MABC Manual Dexterity, AC: MABC Aiming & Catching, BA: MABC Balance, TO:
MABC Total Score, TH: Test of Handwriting Skills.
Regarding the self-report psychosocial outcomes, correlational analyses using Kendall’s
tau revealed several correlations approached significance with the motor measures for the ALL
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survivor group (see Table 25). The Bonferroni adjusted p-value for these correlational analyses
was .0005 (.05/108), which accounts for the multiple tests performed. Lower balance (τ(11) = 0.55, p = .030) and overall motor skills (τ(11) = -0.55, p = .027) on the MABC was associated
with better relations with parents as indicated by the BASC self-report. Also, lower handwriting
performance on the THS was associated with higher self-esteem (τ(11) = -0.50, p = .047).

Table 25
ALL Survivor Group Kendall’s Tau Correlations Between Motor Tasks and Self-Report
Psychosocial Composites and Subscales
PD
PN
VM
VP
MD
AC
BA
TO
TH
INT
-0.26
-0.28
-0.13
0.15
-0.19
0.12
0.14
0.14
0.22
ATP
-0.12
-0.22
0.19
0.31
-0.15
0.00
0.12
0.12
-0.13
LC
-0.08
-0.14
0.02
0.43
0.00
0.20
0.26
0.31
0.35
SS
-0.04
-0.13
0.06
0.28
0.19
0.06
0.18
0.22
0.32
ANX
-0.11
-0.27
-0.02
0.39
-0.14
-0.02
0.06
0.06
0.18
DEP
-0.09
-0.19
0.00
0.31
-0.19
0.08
0.19
0.26
0.38
SIN
-0.34
-0.02
-0.28
0.04
-0.36
0.12
0.02
-0.02
-0.19
PAD
-0.19
-0.08
-0.31
-0.43
-0.28
-0.22
-0.34
-0.40
-0.44
RP
-0.23
-0.41
-0.44
-0.45
-0.31
-0.22
-0.55* -0.55* -0.31
IR
-0.34
0.02
-0.32
-0.32
-0.40
0.06
-0.14
-0.22
-0.11
SE
-0.02
-0.27
-0.10
-0.29
-0.21
-0.17
-0.18
-0.26
-0.50*
SR
0.21
0.11
0.19
0.06
0.15
0.06
0.04
0.04
-0.17
Note. * Trending toward significance p < .05. Correlations include 11 participants. INT:
Internalizing Symptoms Composite, ATP: Atypicality, LC: Locus of Control, SS: Social Stress,
ANX: Anxiety, DEP: Depression, SIN: Sense of Inadequacy, PAD: Personal Adjustment
Composite, RP: Relationship with Parents, IR: Interpersonal Relations, SE: Self-Esteem, SR:
Self-Reliance, PD: Grooved Pegboard Dominant, PN: Grooved Pegboard Non-dominant, VM:
Visual-motor Integration, VP: Visual Perception, MD: MABC Manual Dexterity, AC: MABC
Aiming & Catching, BA: MABC Balance, TO: MABC Total Score, TH: Test of Handwriting
Skills.
For the control group, correlational analyses using Kendall’s tau revealed several
correlations between motor measures and the BASC self-report that approached significance (see
Table 26). Lower visual-perceptual performance was associated with more concerns of atypical
behaviors atypical behaviors (τ(11) = -0.65, p = .007) and symptoms of anxiety (τ(11) = -0.54, p
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= .026) as well as with worse relations with parents (τ(11) = 0.55, p = .022) and less selfreliance skills (τ(11) = 0.60, p = .012). In addition, better visual-motor performance on the Beery
VMI was associated with less self-reported self reliance skills (τ(11) = 0.50, p = .034). Overall,
although correlations that approached significance were observed between motor measures and
parent- and self-report psychosocial functioning, these correlations did not meet the p-value
threshold established by the Bonferroni correction.

Table 26
Control Group Kendall’s Tau Correlations Between Motor Tasks and Self-Report Psychosocial
Composites and Subscales
PD
PN
VM
VP
MD
AC
BA
TO
TH
INT
0.076
-0.187
-0.21
-0.27
-0.52
0.02
0.12
-0.31
-0.08
ATP
-0.173 -0.397
-0.19
-0.65*
-0.31
0.20
0.36
0.10
0.28
LC
0.114
-0.112
-0.21
-0.27
-0.12
-0.10
0.25
-0.10
0.15
SS
-0.019 -0.170
0.19
-0.02
-0.24
-0.12
0.04
-0.17
-0.17
ANX
0.058
-0.21
-0.34
-0.54*
-0.31
0.04
0.29
-0.06
0.04
DEP
0.079
-0.12
-0.24
-0.44
-0.50
0.14
0.37
-0.11
0.09
SIN
-0.245
-0.35
-0.22
0.09
0.14
-0.12
-0.27
-0.14
-0.08
PAD
-0.117
0.11
0.29
0.47
0.19
0.04
-0.19
0.17
-0.08
RP
-0.190
0.11
0.40
0.55*
0.33
-0.06
-0.25
0.12
-0.11
IR
0.152
0.34
-0.25
0.10
0.24
0.33
0.12
0.37
0.11
SE
-0.020
-0.14
0.23
0.00
-0.34
0.04
-0.11
-0.06
-0.25
SR
-0.187
0.04
0.50*
0.60*
0.07
-0.17
-0.33
-0.16
-0.22
Note. * Trending toward significance p < .05. Correlations include 11 participants. INT:
Internalizing Symptoms Composite, ATP: Atypicality, LC: Locus of Control, SS: Social Stress,
ANX: Anxiety, DEP: Depression, SIN: Sense of Inadequacy, PAD: Personal Adjustment
Composite, RP: Relationship with Parents, IR: Interpersonal Relations, SE: Self-Esteem, SR:
Self-Reliance, PD: Grooved Pegboard Dominant, PN: Grooved Pegboard Non-dominant, VM:
Visual-motor Integration, VP: Visual Perception, MD: MABC Manual Dexterity, AC: MABC
Aiming & Catching, BA: MABC Balance, TO: MABC Total Score, TH: Test of Handwriting
Skills.
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Chapter 9: Discussion

The present study sought to further understand motor functioning in pediatric ALL
survivors treated with only chemotherapy. In addition to multiple facets of motor functioning
(e.g., fine motor, gross motor, and visual-motor), the present study sought to characterize motor
adaptation in pediatric ALL survivors. Finally, the study sought to expand upon the existing
body of literature examining motor skills in survivors, as well as how motor functioning relates
to other domains of functioning following treatment, including academic and psychosocial
functioning.
9.1 Motor Functioning in ALL
It was hypothesized that the ALL survivors would perform significantly worse compared
to the age- and sex-matched healthy controls on both performance-based and self-report
measures of motor functioning. Data from the present study supported this hypothesis with
regard to multiple facets of motor functioning.
For fine motor functioning, the ALL survivor group performed significantly worse
compared to the healthy control group on the grooved pegboard task with both the dominant and
non-dominant hands. This result converges with previous literature indicating significant fine
motor difficulties both during and following treatment cessation (Edelmann et al., 2014; Harila et
al., 2009; Hockenberry et al., 2007; Jansen et al., 2008; Kaemingk et al., 2004). Additionally, the
pediatric ALL survivor group displayed significantly worse fine motor performance than the
control group as measured by the manual dexterity task of the MABC. Previous literature
suggested pediatric ALL patients performed in the normative range on this task (Van Brussel et
al., 2006). Temporal differences may account for varying results. Van Brussell and colleagues
collected data on patients five to six years following treatment cessation, while the present study
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captured patients’ fine motor abilities within a year of ending treatment or while they were still
completing maintenance therapy. Nonetheless, results of the present study are congruent with
many late effects studies that highlight significant concerns regarding fine motor abilities with
pediatric ALL survivors.
On gross motor tasks, results of the present study revealed the ALL survivors performed
significantly worse compared to the controls on aiming and catching (i.e., ball skills), balance,
and overall motor skills, as measured by the MABC. These results are consistent with previous
literature suggesting gross motor skills are impaired in ALL survivors treated with only
chemotherapy within one year of treatment cessation (Hartman et al., 2006; Leone et al., 2014).
Specifically, these are highly congruent with Hartman and colleagues’ study, as they also utilized
the MABC to measure gross motor functioning. Present results further exemplify evident gross
motor impairments in children treated for ALL with only chemotherapy during maintenance
therapy or within one year of treatment cessation.
With regard to visual-motor functioning, no significant difference was observed between
the ALL survivors and controls. Although patients with ALL in the present study had completed
treatment or were in maintenance therapy, results are consistent with previous literature on ALL
patients during and at the completion of treatment, which suggest visual-motor skills are intact
(Copeland et al., 1996; Dowel et al., 1989; Espy et al., 2001; Hockenberry et al., 2007;
Krappmann et al., 2007). Several off-treatment and longitudinal studies one to 11 years
following treatment have also revealed intact visual-motor skills in pediatric ALL survivors
(Espy et al., 2001; Kingma et al., 2001). It is optimistic that visual-motor skills remain intact;
however, this brings to question why visual-motor skills are intact in light of observed
impairments in fine motor skills and visual-spatial processing.
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Moreover, the ALL survivors displayed significantly worse performance on a visualspatial task compared to the controls. Given clear visual-spatial and fine motor difficulties, it
may be assumed that the ALL survivors would also display visual-motor difficulties compared to
the controls, since visual-motor skills are the integration of visual-spatial and fine motor skills.
Unexpectedly though, this was not observed in the present study. A possible explanation is that
the fine motor and visual spatial tasks are timed tasks, suggesting they rely on intact processing
speed. Previous literature has consistently revealed processing speed is an evident neurocognitive
weakness in ALL survivors following treatment (Kahalley et al., 2013). Although not formally
tested in the present study, processing speed may partially account for the poor fine motor and
visual-spatial performances observed. When processing demands are low, such as within the
visual-motor task, participants were able to integrate visual-spatial and fine motor skills. In
addition, the impact of age should be considered, as older age was associated with lower
performance on the VMI within the present study. Given the age range of the sample (5–18 years
old), age may have also contributed to the non-significant findings. In sum, further research is
needed to fully understand the variability in visual-motor performance observed across late effect
research; nonetheless, the present study suggests visual-motor skills may remain intact following
treatment for ALL in some circumstances.
On a handwriting task, no significant difference was observed between the ALL survivor
and control groups. Reinders-Messelink and colleagues (2001) found handwriting skills were
impaired in a sample of ALL survivors treated with only chemotherapy. Of note, the metrics
used to quantify handwriting ability in their study were handwriting speed and pressure
(Reinders-Messelink, 2001). Similar to visual-motor skills, handwriting tasks incorporate visualspatial and fine motor abilities; therefore, it may be assumed that handwriting skills would be
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impaired in light of poor fine motor and visual-spatial skills. However, as mentioned above, the
visual-spatial and fine motor tasks incorporated in this study are timed. The handwriting task
used in the present study was not timed, which decreased the processing speed demands on the
participants. The processing speed component of Reinders-Messelink and colleagues’
handwriting task may explain the discrepant results. Also, as mentioned with visual-motor skills,
age should also be considered since older age was significantly correlated with lower
performance on the handwriting task.
Results on self-report data were variable. For parent-report, results from the MABC
suggested parents of pediatric ALL survivors had significantly more concerns regarding their
child’s motor skills compared to healthy controls. This converged with data from Sabarre and
colleagues (2008), which revealed 57% of the parents in their sample of pediatric ALL survivors
treated with only chemotherapy had concerns regarding their child’s motor skills, as reported by
the MABC Checklist. Alternatively, no significant difference was observed using the DCDQ.
One possible explanation is that the DCDQ was developed to screen for children with
developmental motor difficulties consistent with the DSM diagnosis of Developmental
Coordination Disorder (Wilson et al., 2009). Also, this measure has been infrequently used
within medical populations, such as pediatric oncology. Therefore, although DCDQ is sensitive
to identifying motor difficulties consistent with DCD, it may not be sensitive to the motor
concerns present in pediatric oncology. Nonetheless, the MABC Checklist identified significant
differences in motor performance via informant report, suggesting pediatric ALL survivors also
experience significant motor challenges in their day-to-day lives following treatment.
In previous literature, child-report of physical and motor abilities has offered a unique
perspective to understanding motor functioning, above and beyond parent-report and objective
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measures (Kennedy et al., 2012). Results of the present study revealed several significant
findings regarding child-perspectives of motor functioning. The ALL survivors reported
significantly lower perspectives of overall physical abilities compared to the controls. Results
partially converged with previous literature on Spanish-speaking pediatric cancer survivors who
also reported lower flexibility and health on the PSDQ (Bragado et al., 2008); however, several
other PSDQ were significant within the present study. Specifically, the ALL survivors reported
lower perspectives of appearance, health, flexibility, and endurance compared to the controls. In
addition, results of the present study provide additional evidence for the utility of the PSDQ in
the pediatric oncology population. In a recent study by Wurz and Brunet (2017), adolescent and
young adult cancer survivors indicated the PSDQ was a relevant and appropriate measure for
assessing physical activity and physical abilities. Taken together, the PSDQ identified several
notable discrepancies between ALL survivors and controls with regard to physical self-concept,
providing a deeper understanding for the ways in which physical abilities and physical self
perspectives may be impacted following ALL treatment.
9.2 Motor Adaptation.
It was hypothesized that the ALL survivor group would perform significantly worse on a
motor adaptation task compared to healthy controls. Contrary to predictions, results revealed no
significant differences in motor learning between the groups across all variables, including
change in performance across the task and after effects. Performance suggests the ALL survivors
were equally capable of adapting to the demands of the motor learning task. Given the
discrepancies between the groups in other domains of motor functioning, it was surprising that
there were no significant differences between the groups on the motor learning task. Of note,
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performance on the motor adaptation task was also not correlated with other motor tasks as
hypothesized for either the ALL group or for the control group.
The cerebellum, which plays a primary role in motor adaptation, can be adversely
impacted by chemotherapy, specifically methotrexate (Leznik et al., 1998; Sugiyama et al.,
2015). Leznik and colleagues (1998) reported significant deficits in prefrontal and cerebellar
regions in pediatric ALL survivors treated with chemotherapy only before 5 years old. They also
created a composite of neuroanatomical data to assess the relationship between cerebellar-frontal
regions as one construct with performance on neuropsychological tests (Leznik et al., 1998).
Results suggested the cerebellar-frontal composite was significantly correlated with visual-motor
abilities. The authors concluded that deficits in cerebellar-frontal regions may account for visualmotor sequelae in ALL survivors treated at a young age.
These research findings bring to question why the results of the present study did not
reveal deficits in motor learning, a cerebellar-dominant skill. First, Leznik and colleagues’
sample included patients younger than those in the present study; therefore, the impact of
methotrexate on cerebellar function may be more prominent in younger patients. Second, the
present study does not include neuroanatomical data on the integrity of the samples’ cerebellum;
therefore, it cannot be inferred whether the participants in the present study were equally
impacted by methotrexate as those in Leznik’s and colleagues’ work. Nonetheless, results
suggest that, despite evident motor difficulties, the ALL survivor group was equally capable of
learning a novel motor task as the healthy controls, which may suggest survivors have the
potential to relearn motor skills.
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9.3 Relationship Between Motor and Academic/Psychosocial Functioning
It was hypothesized that visual spatial skills and fine motor functioning, considered
primary skills in white matter models, would significantly correlate with visual-motor
functioning in the ALL survivor group. Inconsistent with predictions, visual-perceptual skills
were not related with visual-motor skills within either group. However, results indicated fine
motor abilities, as measured by the grooved pegboard task with both hands, were significantly
related to visual-motor abilities within the ALL survivor group; however, this relationship was
not observed within the control group. These results are consistent with white-matter models
suggesting that damage to white matter can result in fine motor difficulties, which further impact
secondary skills, such as visual-motor ability (Rourke 2002). In addition, these results contradict
those by Knight and colleagues, which revealed no significant relationship between visual-motor
and fine motor skills in ALL survivors; however, as previously mentioned, their study assessed
patients several years following treatment cessation. Therefore, it is possible that the relationship
between fine motor and visual-motor abilities occurs primarily at or shortly after treatment
cessation.
It was also hypothesized that performance based measures of motor functioning would
significantly correlate with academic functioning within the ALL survivor group. Results
revealed no significant relationships between motor functioning and academic abilities across
both groups. Results contradict previous literature suggesting fine motor and visual-motor
abilities were related to academic skills within both pediatric ALL survivors treated with only
chemotherapy (Balsamo et al., 2015; Kaemingk et al., 2004; Moore et al., 2016) as well as
healthy children (Cummins et al., 2005; Davis et al., 2011). One possible explanation is that the
present study utilized the WRAT, whereas the studies mentioned above used alternative, more
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comprehensive achievement measures, such as the Wechsler Individual Achievement Test
(WIAT) and Woodcock-Johnson Tests of Achievement. In addition, the mean standard scores for
math and spelling for the ALL survivors fell in the average range, similar to the control group.
Therefore, it is possible that the ALL survivors in the present study had higher academic
abilities, which may have mitigated the relationship previously observed between motor skills
and academic abilities in late effect research.
In addition, it was hypothesized that performance based measures of motor functioning
would significantly correlate with psychosocial functioning, including internalizing symptoms
and adaptive behaviors as reported by parents and children. For parent report, the child’s motor
skills significantly correlated with somatization and leadership on two subscales (i.e.,
somatization and leadership) for the ALL survivor group. Alternatively, within the control group,
motor skills were found to correlate with parent-report of four subscales (i.e., anxiety,
depression, adaptability, and social skills) and both composites (i.e., Internalizing Symptoms and
Adaptive Skills). A similar pattern was observed for child report. Motor skills only correlated
with two subscales for the ALL survivor group (i.e., relationship with parents, and self-esteem);
however, motor skills correlated with four subscales for the control group (i.e., atypicality,
anxiety, relation with parents, and self-reliance). Given the sample size, it is challenging to
postulate the meaning of each individual correlation (e.g., grooved pegboard dominant hand and
depression); however, some hypotheses can be made about this pattern of data. This pattern of
results is inconsistent with the white matter model assumptions in that white-matter damage in
pediatric ALL survivors would result in motor impairments cascading into psychosocial
difficulties (Carey et al., 2007; Rourke, 2002). Alternative explanations may be considered. First,
findings may be an artifact of methodological limitations. The sample size limited the statistical
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approach. Secondly, research has indicated pediatric ALL survivors report greater concerns
regarding internalizing symptoms and social functioning compared to healthy controls (Carey et
al., 2001; Carey et al., 2007). It is possible that difficulties in motor functioning are subtle in
comparison to the magnitude of stress pediatric ALL survivors experience and only partially
account for psychosocial difficulties. Alternatively, for healthy children, motor impairments may
be at the forefront of their concerns and, therefore, more strongly relate to their psychosocial
functioning.
9.4 Clinical Implications.
Clinical practices have shifted toward using standardized follow-up care protocols to
identify late effects, including neurocognitive and psychosocial. The present study provides
further evidence for the necessity to also include screenings for motor difficulties. Jansen and
colleagues’ (2008) research revealed assessing motor functioning during treatment is feasible
and also enjoyable to patients. Therefore, it may be presumed that it would also be feasible to
continue monitoring motor skills following treatment cessation to determine if treatment is
warranted. Although several studies have suggested motor difficulties may dissipate after
treatment (Copeland et al., 1996; Dowell et al., 1989; Hockenberry et al., 2007; Krappmann et
al., 2007), results of the present study are congruent with alternative studies suggesting motor
difficulties persist in patients within a year of completing treatment (Edelmann et al., 2014;
Hartman et al., 2006; Jansen et al., 2008; Leone et al., 2014). Therefore, it is pertinent that
medical professionals are cognizant of these motor challenges and include screeners and
assessments for motor difficulties in their late-effect evaluations.
In addition, several families shared personal notes regarding their child’s motor skills
following treatment. A theme was noted in several comments in that families faced barriers with
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insurance companies. For example, parents reported difficulties obtaining physical and
occupational therapy services due to the patient’s shifting between inpatient and outpatient care
on multiple occasions during their treatment. Results of the present study, along with a strong
body of literature investigating motor late effects may provide the greater medical community,
including providers and insurance companies, stronger evidence for the necessity for screening
and intervening on motor difficulties in pediatric ALL survivors.
9.5 Limitations
The present study has several limitations that warrant discussion, particularly with regard
to sampling and methodology. The present study included a small, physician-referred, single-site
sample size. Of note, many late-effect studies assessing neuropsychological outcomes in
pediatric cancer survivors include small samples. Nonetheless, the size of the sample may have
impacted the results. Given that there was no randomization, it is possible that participants and
families who elected to participate only represent a fraction of the general population. Moreover,
patients and families from the ALL survivor group may have had pre-existing concerns
regarding the child’s motor functioning, which motivated them to participate in the study;
whereas, survivors with limited concerns may have been less likely to participate. Also, the
sample included a broad age range. Of note, the fact that most of the results were standardized
using age-normative data hopefully decreased the negative impact of age on the results. Diversity
factors were also a limitation in the present study, as the sample was primarily Caucasian and the
control group had no representation within the lower bracket of socioeconomic status.
Methodological concerns should also be discussed. First, the principal investigator was
the primary assessor; therefore, the assessor was not blind to the study design and proposed
hypotheses. This may have introduced bias into the assessments and scoring. Second, the sample
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size impacted the statistical methods. For example, no conclusions could be made on the effect
of various treatment agents, such as dose of methotrexate, on the outcome variables, given the
constraints the sample size placed on the analyses. Similarly, the sample size limited the options
for statistical analyses, as more sophisticated analyses, such as structural equation modeling,
could not be used to assess the relationship between outcome variables. Thus, the proposed
model illustrated in Figure 1 could not be directly tested. And finally, the present study used a
wide range of dependent variables across a small sample, limiting the normality of the data.
Overall, the present study had various sampling and methodological limitations, consistent with
other late-effect research studies, and future research should aim to decrease these limitations to
broaden the generalizability of the findings.
9.6 Future Directions
Continued efforts to understand motor functioning in pediatric ALL survivors are
necessary. Studies with larger samples of diverse patients will assist in characterizing motor
deficits in this chronic medical population. Also, incorporating information regarding survivors’
brain functioning and neuroanatomy using neuroimaging will be crucial in fully understanding
motor-related late effects. Given the impact age had on several variables within the present
study, as well as literature supporting the impact of age at diagnosis and treatment on
performance, it is important that researchers investigating motor late effects consider the age of
the sample. This may include controlling for age in analyses or assessing motor functioning
between refined age groups in addition to age as a continuous variable. A more thorough
investigation of the effect of treatment factors, including specific agents and doses, may also be
helpful in understanding the manifestation of motor deficits in pediatric ALL survivors. Analysis
of external factors that may influence premorbid motor functioning, such as previous sport
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experience or amount of time playing video games, may also be considered when assessing
motor functioning in pediatric ALL survivors.
In addition to sample characteristics and covariates, temporal factors should also be
explored. Longitudinal studies investigating the trajectory of motor deficits are important to help
characterize motor functioning during and following treatment. Additionally, longitudinal studies
may be used to assess whether the impact motor functioning has on other domains of
functioning, including academic and psychosocial, differs depending on the stage of treatment or
time since treatment cessation. Also, the present study revealed significant differences in selfperceptions of physical abilities between ALL survivors and controls; longitudinal data would
assist in understanding how self-perceptions may change over the course of treatment and
recovery. And lastly, pediatric ALL survivors occasionally receive occupational and physical
therapy services during and following treatment. It would be interesting to use longitudinal
analyses to assess whether motor functioning in pediatric ALL survivors across the various
stages of treatment differs dependent on if and when the patient received therapeutic services.
Lastly, results of the present study provided some evidence for how motor functioning
variables relate to one another and with other domains of functioning. Future investigations are
needed to continue investigating the impact of motor deficits on the daily lives of pediatric ALL
survivors. Specifically, it is of interest as to how motor functioning may relate to or predict other
health-related outcomes, including pain, physical fitness, and obesity, all of which have been
identified as late effects in child cancer survivors. A more thorough investigation of these
relationships may assist in improving the overall quality of life of pediatric ALL survivors.
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Chapter 10: Conclusion

The present study provided further evidence for the existence of motor deficits in
pediatric ALL survivors, treated with only chemotherapy, while on maintenance therapy or
within a year of treatment cessation. These results add to the existing body of literature
emphasizing motor impairments following treatment for ALL. Additionally, these results provide
further support for the potential need to screen for motor difficulties and provide therapeutic
services for motor impairments following treatment. In addition to clinical implications, results
of the present study highlight the need for continued research on motor functioning in pediatric
survivors of cancer. As observed in the present study, future research should include objective
measures of motor abilities as well as parent- and child-reports given that each component may
provide a unique perspective for understanding survivors’ motor abilities. Additionally,
continued research efforts, including neuropsychological and neuroimaging data, are needed to
understand how evident motor impairments impact the child’s quality of life across domains of
functioning, including academic, cognitive, psychosocial, and physical functioning. Taken
together, children treated for ALL experience significant motor difficulties following treatment,
as evidenced by the present study along with the existing literature; therefore, it is critical that
late effect research and survivor follow-up care include motor functioning in assessments and
treatment to assure optimal quality of life for pediatric ALL survivors.
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